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CHAPTER 1 - STROKE INTRODUCTION AND MITOCHONDRIAL MECHANISMS OF 
ISCHEMIA/REPERFUSION INJURY  
Stroke: Background, Anatomy and Gross Pathophysiology 
Focal brain ischemia, i.e., stroke, is one of the leading causes of death and 
disability in the Western world.(Feigin, Norrving, and Mensah 2017) These 
cerebrovascular events are normally subdivided into hemorrhagic and ischemic strokes. 
Hemorrhagic strokes occur when an intracranial vessel ruptures, filling the subdural, 
subarachnoid or intracerebrum with blood and account for about 6.7% of stroke 
presentations to the Emergency Department. Ischemic strokes, on the other hand, occur 
when a blood vessel becomes occluded thus cutting off the adjacent brain tissue from 
critical blood supply. Most occlusions are cardioembolic, resulting from underlying cardiac 
arrhythmias such as atrial fibrillation, or congenital heart abnormalities such as a patent 
foramen ovale but these are not the only causes.(Chung J‐W Fau - Chung et al. 2014) 
Large vessel atherosclerosis in the internal carotid artery, as well small vessel disease 
resulting from uncontrolled hypertension can all lead to focal brain lesions.(Chung J‐W 
Fau - Chung et al. 2014)  
Neurons rely almost entirely on oxidative phosphorylation to meet their high 
metabolic demands and so any disruption of blood supply to an area of the brain causes 
rapid, irreversible neuronal death.(Attwell and Laughlin 2001; Yellen 2018) For this 
reason, swift stroke intervention is needed in the clinic to restore blood supply to the 
affected tissue and thus save neurons – and by extension reduce stroke mortality and 
disability. To date, the only clinically approved therapies to reverse the ischemia and 
restore blood flow which carries crucial oxygen and metabolites to the starved neurons 
are either pharmacological, in the form of tissue plasminogen activator (tPA) or surgical 
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as seen in endovascular thrombectomy.('Tissue Plasminogen Activator for Acute 
Ischemic Stroke'  1995; Hacke 2015) Both of these interventions have been correlated 
with improvement in stroke outcomes though only a relatively small subset of the stroke 
patient population meets the stringent criteria to receive such treatments.  
Affected ischemic brain tissue, however, cannot be considered homogenously. 
The anatomy and physiology of cerebral blood supply allows for tight regulation during 
vast physiological and pathophysiological fluctuations of cerebral blood flow. The brain 
receives its blood from four major vessels, two of which branch off the subclavian arteries 
and two directly from the aorta. The former, the carotid arteries, bifurcate in the neck into 
the external which courses into the face and the internal which inters at the base of the 
brain. The two vertebral arteries run parallel to the vertebral column and join together at 
the base of the brain to form the basilar artery. These arteries, along with adjoining 
“communicating arteries” form an anastomosis that was named after the famous 
physician Thomas Willis – forming the Circle of Willis. Of note, the internal carotid artery 
forms the origin of the middle cerebral artery (MCA) which supplies blood to the cortex 
through its cortical branches, as well as to the striatal subcortical structures through its 
lenticulostriate branches.(Liebeskind 2003) There are thus six arteries that supply blood 
to the brain: the right and left anterior, middle, and posterior cerebral arteries which are 
connected within the Circle of Willis by the communicating arteries at the origins, and by 
Heubner’s leptomeningeal anastomoses at their distal ends. Thus, any extra-cranial 
occlusion of one artery results in adequate perfusion throughout the brain through the 
other six arteries. This very elegant system ensures that the brain receives a constant 
supply of blood.(Hossmann 2009)  
When an occlusion of one of these arteries within the brain takes place, neurons 
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directly proximal to the occluded vessel that receive their blood supply from it rapidly 
deplete their ATP stores and become at risk for dying in the absence of immediate 
intervention. Because neurons rely so heavily on mitochondrial ATP to maintain their ionic 
gradients, any disruption in oxidative phosphorylation leads to ionic equilibration, 
especially sodium, across the membrane resulting in rapid depolarization as well as an 
influx of water leading to cytotoxic edema.(Rungta et al. 2015) However, sodium is not 
the only ion to move down its concentration gradient into the cell, calcium also rapidly 
flows in, taxing the already dysfunctional mitochondria and initiating delayed neuronal 
death cascades – a crucial factor in disease progression.  
In 1977 Astrups et al. published a seminal study in which they provided 
electrophysiological evidence that following focal brain ischemia in the primate brain, 
evoked cortical potentials could be transiently abolished in a manner directly related to 
the rate of blood flow.(Astrup J Fau - Symon et al. 1977) Simply put, as blood flow fell 
below critical thresholds, recovery of neuronal activity became more difficult. But, moving 
away from this core of inactivity directly proximal to the occlusion resulted in a zone of 
transient electrical quiescence that could be reversed upon restoration of flow to 
physiological levels. When collateral flow to these neurons was increased by increasing 
systemic blood pressure, these neurons could once gain reach action potential. Perhaps 
even more interestingly, it was noted that if ischemia were to persist beyond a critical 
window, even these neurons would undergo anoxic depolarization and subsequently die. 
Thus, it was found that regions of focal brain ischemia contained neurons that died in a 
flow-dependent and time-dependent manner.  Astrups et al. called this area the penumbra 
and it came to be defined as a hypoperfused area of the parenchyma that was fed by 
collateral flow that was shunted to the area through changes in arterial pressure and local 
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factors.(Astrup, Siesjö, and Symon 1981) Because these neurons do not initially die they 
could be potentially salvaged by a therapeutic intervention.  
This was a shocking discovery that is anatomically intuitive: moving away from the 
occlusion, neurons receive retrograde flow from Heubner’s pial anastomoses and thus 
remain potentially viable. Much research has been conducted following Astrups’ study to 
determine the viability of these neurons based on the rate of blood flow they 
receive.(Astrup, Siesjö, and Symon 1981; Mies et al. 1991; Hossmann 2009) Different 
neuronal functions break down across the ranges of flow reduction. It has been shown, 
for example, that protein synthesis is reduced by 50% when cerebral blood flow rates 
drop to 0.55 ml/g/min and stops below 0.35 ml/g/min. Anoxic depolarization takes place 
at much lower flow rates – at 0.06 - 0.15 ml/g/min extracellular ion changes, including but 
not limited to extracellular reductions in calcium due to the opening of calcium 
channels.(Hossmann 2009) Thus, rather than being a homogenous region, the ischemic 
parenchyma can be thought of as a shadowy zone in which neurons are undergoing 
multifaceted dysfunction depending on the extend of blood flow reduction.  
Taken together, stroke therapy seeks to restore blood supply and save these 
penumbral neurons. However, re-oxygenation results in substantial tissue damage due 
to the production of Reactive Oxygen Species (ROS).(Granger and Kvietys 2015) 
Ischemia-reperfusion injury has proven to pose a perplexing clinical problem: while rapid 
restoration of blood is crucial in salvaging the penumbra, doing so can exacerbate brain 
injury due to the production of ROS.(Carden and Granger 2000; Raedschelders, Ansley 
Dm Fau - Chen, and Chen 2012)  
Role of Mitochondria in Ischemia Reperfusion Injury 
Studies have shown that the mitochondria play a pivotal role in the production of ROS 
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which goes on to further damage cells during reperfusion, but their role is not limited to 
this.(Murphy 2009) Mitochondria also initiate type II apoptosis through the release of 
apoptogenic proteins such as cytochrome c, APAF-1 and SMAC-DIABLO which lead to 
a cell death phenotype similar to apoptosis known as delayed neuronal death.(Green and 
Reed 1998) In what follows, we shall discuss mitochondrial mechanisms of cerebral 
ischemia reperfusion in greater detail, and outline unique findings in the Hüttemann-
Sanderson laboratories that allow for the convergence of these mechanisms on the 
complex regulation of the mitochondrial membrane potential.  
Oxidative Phosphorylation Summarized 
A single molecule of glucose produces 38 ATP molecules: 2 from glycolysis, 2 from 
the Krebs cycle, and 34 from oxidative phosphorylation via the mitochondrial electron 
chain. Thus, oxidative phosphorylation plays a critical role in providing sufficient ATP to 
meet the cell’s energy demands.(Krebs et al. 1953)  
Glucose is fully oxidized during glycolysis and the TCA cycle, the latter of which 
takes place in the mitochondrial matrix.(Krebs et al. 1953) Energy is then stored in the 
reduced electron carriers NADH and FADH2. These two carries donate their electrons to 
the complexes of the electron transport chain and are then passed from complex to 
complex which is coupled to proton pumping from the matrix to the intermembrane space. 
There are two primary sites through which electrons enter the electron transport chain: 
complex I (NADH dehydrogenase), and complex II (succinate dehydrogenase). 
Mammalian complex I is comprised of about 45 subunits, containing Flavin 
mononucleotide (FMN) that is not covalently bound and serves as the point of entry for 
electrons, and an iron-sulfur clusters.(Lenaz et al. 2006) When NADH is oxidized, two of 
its electrons are eventually transferred to ubiquinone (Coenzyme Q, CoQ).(Hirst et al. 
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2003; Sazanov 2007) Complex I is also a major site of ROS production.(Murphy 2009) 
Based on bacterial studies, there are seven iron sulfur clusters that pass electrons from 
FMN to CoQ.(Sazanov 2007) When O2 reacts will the reduced FMN, superoxide can form, 
though this is not the primary mechanism of ROS production during reperfusion which 
likely occurs due to the semiquinone free radical which will be discussed below. It is also 
worth noting that the reduction state of FMN is determined by the NADH/NAD+ 
ratio.(Kussmaul and Hirst 2006; Murphy 2009; Hirst, King Ms Fau - Pryde, and Pryde 
2008) Thus, any changes in this ratio by, say, ischemia will increase the NADH/NAD+ 
ratio and result in superoxide being formed. It must be noted that an additional mechanism 
of ROS formation by complex I occurs during reverse electron transport (RET).(Adam-
Vizi and Chinopoulos 2006; Kudin et al. 2004; Votyakova 2001; Liu, Fiskum G Fau - 
Schubert, and Schubert 2002) This occurs when the CoQ supply is reduced by electrons 
and when the proton motive force is large enough to push electrons back from CoQH2 
into complex, reducing NAD+ to NADH.(Chance 1961) Moreover, when substrate 
succinate concentrations are high, RET can take place through complex I.(Liu, Fiskum G 
Fau - Schubert, and Schubert 2002)  What is significant to this study about RET is the 
directly responsibility of Δpm and thus even small reductions in Δpm can halt the entire 
process by reducing the electrostatic forces that drive electrons to the sits where 
superoxide might be produced.(Lambert 2004; Votyakova 2001) Further noteworthy is 
that complex I produces ROS in proportion to the pH gradient rather than the membrane 
potential.(Lambert 2004; Liu 1997; Murphy 2009)   
From complex I, electrons are transferred to complex III (bc1 complex) via the 
electron carrier ubiquinone.(Mitchell 1975b, 1975a; Crofts 1998, 2004; Trumpower 1976; 
Chobot 2008; Osyczka 2005) It is necessary to outline the Q cycle in some detail as 
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complex III is a site of ROS generation.(Cadenas E Fau - Boveris et al. 1977; Turrens, 
Alexandre, and Lehninger 1985) Briefly, ubiquinol (QH2) binds to the Qo site of complex 
III while ubiquinone binds to the Qi sight. Ubiquinol then gives up its electron  to the iron-
sulfur cluster of the enzyme and to the bL heme group. This oxidation reaction results in 
the generation of a temporary radical, semiquinone which goes on to become completely 
oxidized forming ubiquinone, which leaves the Qo binding site – and it is in fact center P 
of the Qo site where superoxide is most formed by complex III. The iron-sulfur cluster 
which has received one electron from ubiquinol, loses the electron and then translocates 
to the cytochrome c1 subunit where it donates its electron to cytochrome c which then 
dissociates from complex III. Furthermore, oxidation of the iron-sulfur cluster also 
releases a proton into the intermembrane space which comes from Q10. The additional 
electron reduces the bH heme which then transfer it to the second ubiquinone molecule 
at the Qi site. This electron must move against its electrical gradient because it must go 
to the negatively charged membrane. Ubiquinone then becomes reduced to the 
semiquinone radical which requires a second Q cycle to transfer an electron to reduce 
semiquinone to ubiquinol. Thus, in summary, the Q cycle pushes four protons into the 
intermembrane space. From here, cytochrome  c carries its electrons which are bound to 
the heme group to complex IV. Cytochrome c also has a role in apoptosis, which shall be 
discussed in greater detail below.  
The combination of moving electrons and pumping protons generates the proton-
motive force which is the crux of the chemiosmosic hypothesis first formulated by Peter 
Mitchell which drives oxidative phosphorylation as it converts electro-chemical energy 
into mechanical energy.(Mitchell and Moyle 1967) This process produces the proton 
motive force, Δpm which is comprised of the electrical component known as the 
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mitochondrial membrane potential (ΔΨm) and the chemical component which is the pH 
difference across the inner mitochondrial membrane. The proton motive force can be 
outlined according to the following equation: Δpm = ΔΨm - 59ΔpH and in higher organisms, 
the electrical potential (ΔΨm) is the major driver of the proton motive force. In intact 
mitochondria, the protons that have accrued in the intermembrane space enter into the 
Fo complex of ATP-synthase and exit through the matrix. Their stored potential energy is 
converted to kinetic energy as they rush down their concentration gradient, clockwise 
rotating Fo and the stalk (around 6000 rpm). This rotation induces conformational changes 
in the head proteins that force ADP and Pi close enough together to bind thus forming 
ATP. ATP is then transported out of the matrix by a group of mitochondrial carrier proteins, 
specifically ATP/ADP translocase.  
OxPhos Regulation 
The electron transport chain has evolved in such a way as to allow the cell to meet 
its energy demands according to its needs. In order to achieve this goal, the functions of 
the ETC must be carefully regulated by a number of mechanisms. As we have seen, the 
proton motive force drives ATP production through a carefully orchestrated sequence of 
steps in which electrons are passed between ETC complexes and protons are shuttled 
into the intermembrane space thus generating an electrochemical gradient that powers 
complex V, ATP-synthase. Classically, the proton motive force and the mitochondrial 
membrane potential are regulated by the amount of substrate present and respiratory 
control.  
At their core, the enzymes of the ETC are regulated by the presence or absence 
of substrate or product.(Arnold and Kadenbach 1999; Kadenbach et al. 2010) ATP and 
ADP can activate or inhibit cytochrome c oxidase (CcO), respectively, according to the 
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cell’s energy needs. When ATP binds to cytochrome C, the reaction between cytochrome 
c and cytochrome c oxidase is curbed. CcO is modulated by the presence of ATP/ADP 
by means of its binding pocket located in the matrix domain and resulting in the inhibition 
of the enzyme when ATP is present and activation when there is more ADP.  
In addition to the presence of substrate or product, the proton motive force itself 
regulates respiration by a process known as respiratory control. Originally demonstrated 
in the 1950s in isolated mitochondria, respiratory control occurs when the proton motive 
force itself inhibits the proton pumps of the ETC once the proton gradient passes a certain 
threshold thus not allowing for further protons to be pumped when Δpm is high.(Chance 
B Fau - Williams and Williams 1955) In vivo, the reduction of the proton gradient because 
of ATD + Pi being converted to ATP by complex V allows the proton pumps to reinitiate 
electron transfer and proton pumping. In situations of excess of ATP, such as resting 
mitochondria, Δpm increases to an inhibitory threshold and thus proton pumping ceases 
and so does respiration. This mechanism, which is connected to electron transport and 
thus ΔΨm allows for tight regulation of mitochondrial membrane potential between 80 and 
140 mV which optimizes energy production and minimizes ROS.(Sanderson et al. 2013)  
While these basic mechanisms govern respiration in both prokaryotic and 
eukaryotic organisms, in recent years it has been demonstrated that higher eukaryotic 
organisms exhibit additional levels of respiratory control. Evidence for this can be found 
in increased complexity of eukaryotic ETC complexes – e.g., bacterial CcO contains 2-4 
subunits whereas mammalian CcO is comprised of 13 subunits for each monomer and 
operates as a dimer.(Tsukihara et al. 1996; Huttemann et al. 2008)  
As we have seen, Cyt c transfers electrons from the bc1 complex to cytochrome c 
oxidase and in recent years has been shown to be subject to modulation by intracellular 
10 
 
signaling cascades. Specifically, studies on isolated enzyme have shown several 
phosphorylation sites. Lee et al. found that phosphorylation of cow heart Cyt c resulted in 
inhibition of the enzyme thus providing evidence for post-translational enzymatic control, 
and the inhibitory effect of phosphorylation.(Lee et al. 2006) Perhaps further solidifying 
this point were in vitro analyses performed by the Hüttemann lab with isolated enzyme 
from cow liver.(Yu et al. 2008) The group examined the Tyr-48 phosphorylation site and 
found that when phosphorylated, the maximal turnover of Cyt c was 3.7/sec; however, 
when the enzyme was dephosphorylated, activity increased drastically to 8.2/sec which 
amounted to a 2.2 fold increase. Thus, it can be concluded from these studies that the 
maximum number of chemical conversions of the substrate per second that a single 
catalytic site of Cyt c can complete decreases when the enzyme is phosphorylated and 
drastically increases upon dephosphorylation – a phenomenon which occurs during 
periods of cellular stress (brain ischemia, in particular).(Huttemann et al. 2008)  
Having seen that Cyt c can be reversibly phosphorylated and deposphorylated and 
this activity can alter enzymatic reaction rates, the next question for us to ask is whether 
other ETC enzymes capitulate to the same principles. Of interest to this work in particular 
is how cytochrome c oxidase can be affected by phosphorylation/dephosphorylation. 
Early studies have shown in rat heart mitochondria that CcO can be phosphorylated by 
at residue Tyr304(Steenaart and Shore 1997); however, many of the early experiments 
failed to show the relevance of CcO phosphorylation because the enzymes had been 
removed from their native cellular environment. To address these shortcomings, the 
Hüttemann lab used liver issue to look at the cAMP signaling pathway and its effect on 
CcO activity. They found that high levels of cAMP resulted in the phosphorylation of the 
enzyme. Perhaps even more interestingly, once phosphorylated, enzymatic activity was 
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strongly inhibited even in the presence of high, non-physiological levels of substrate, 10 
μM cytochrome c.(Lee et al. 2005) Furthermore, the cAMP pathway appears to be tissue-
specific. Relevant to this study is the finding that under conditions of ischemia, CcO 
changes its phosphorylation state as was shown in rabbit heart.(Fang et al. 2007; Prabu 
et al. 2006) Guo et al (2007) showed that hypoxic stress induces increases in protein 
kinase C (PKC) signaling, specifically the PKCε isoform.(Guo et al. 2007) PKCε was 
found to co-localize with CcO during ischemia and its presence resulted in increased 
activity.(Ogbi and Johnson 2006; Ogbi et al. 2004) Furthermore, Ty304 on CcO was found 
to be reversibly phosphorylated where deposphorylation resulted in increased enzyme 
activity.(Huttemann et al. 2008)  
The theory, then, is that cellular stress, like ischemia, causes changes in the 
phosphorylation states of the ETC complexes. In general, when the OxPhos enzymes are 
phosphorylated, they are inhibited thus reducing proton pumping and maintaining the 
membrane potential between 80 and 140 mV. However, during times of cellular stress, 
enzymes are dephosphorylated or change their phosphorylation state, which rapidly and 
drastically increases their activity, hyperpolarizing the membrane. Thus, ETC complexes 
can be found in multiple states of phosphorylation that directly regulates their activity. 
Hüttemann et al. argue that complexes I, III, and IV (which are the proton pumping 
complexes) undergo structural changes upon phosphorylation so that already 
intermediate (physiological) membrane potentials lead to inhibition of proton 
pumping.(Huttemann et al. 2008) When these complexes are dephosphorylated, 
however, they become maximally active and the membrane potential can only inhibit 
proton pumping once it has reached much higher pathological levels.  
Membrane Potential and ROS 
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The mitochondrial membrane potential is tied to activation states of the OxPhos 
complexes and the production of ROS under conditions of cellular stress. The 
electrochemical gradient, or proton motive force, is comprised of the mitochondrial 
membrane potential, ΔΨm, and the pH difference across the membrane due to the proton 
pumping (the inner membrane being highly impermeable to protons). The electrical 
component, which is the greatest contributor to the proton motive force in mammals, can 
be measured using voltage-dependent fluorescent dyes such as tetramethylrhodamine 
methyl ester (TMRM).  
While there are species and tissue specific differences in ΔΨm, generally the 
membrane potential during physiological conditions is kept between 80 and 140 mV. 
Moreover, Hüttemann et al. have argued that reversible phosphorylation, which was 
discussed in detail in the previous section, is the mechanism by which ΔΨm is 
regulated.(Huttemann et al. 2008)  
Under normal physiological conditions oxygen is fully reduced to H2O by CcO with 
only a small number of electrons leaking and reacting with O2 to form superoxide. 
Superoxide is produced at complexes I and III and is released mostly into the matrix by 
complex I and the intermembrane space by complex III. In both cases, superoxide 
generation has been shown to be dependent on membrane potential. When ΔΨm is 
maintained within physiological range, ROS is minimized and ATP production can 
proceed as needed. Moreover, it must be noted that any ROS that is produced at low 
ΔΨm takes place by mechanisms other than membrane potential.(Suski et al. 2012) Thus, 
ROS are formed by complexes I and III at higher membrane potential and, relevant to this 
study, are exponentially produced when the membrane is hyperpolarized (that is, greater 
than 140 mV).(Liu 1999; Starkov and Fiskum 2002; Liu 2010; Korshunov, Skulachev Vp 
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Fau - Starkov, and Starkov 1997) In complex III, once the half-life of semiquinone radical 
at the Qo site is extended by ΔΨm, the radical is able to react with dioxygen to form 
superoxide.(Song and Buettner 2010)  
Superoxide, once generated, reacts with water to generate H2O2 or protons to 
produce even more ROS such as peroxides and hydroxyl radicals. ROS destroy cells as 
they damage DNA, RNA, proteins, and lipids. Moreover, the half-life of most radicals is 
very short ranging from nanoseconds to seconds.  
Role of Mitochondrial Metabolites in ROS Production 
A compelling study was performed by Couchani et al. in which they investigated 
whether mitochondrial ROS during ischemia/reperfusion injury were produced by 
metabolites.(Chouchani et al. 2014)  To interrogate their hypothesis, they utilized a 
metabolomics approach in which they quantified conserved metabolites in several tissues 
during ischemia/reperfusion injury. Using liquid-chromatography-mass spectrometry on 
tissues harvested from pig brain, kidney, liver, and heart that underwent in vivo ischemia, 
they found three primary metabolites elevated in all tissues: xanthine, hypoxanthine, and 
succinate. Of the three, succinate was increased the most.  
Succinate that had accrued during ischemia returned to normal levels within 5 
minutes in ex-vivo tissue and in in vivo hearts. Furthermore, succinate accumulations 
occurred in areas that had undergone ischemia and were marked by a striking absence 
of other Krebs Cycle metabolites. It was thus concluded that succinate accumulates 
rapidly during ischemia and is metabolized when flow is re-established which happens to 
correspond to the same time-frame as ROS production.  
Succinate is produced in the mitochondria during the Krebs cycle and via the 
GABA shunt. Using radio-labeled carbon, Couchani et al. concluded that succinate 
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accumulation during ischemia does not take place from the usual carbon sources of 
metabolism. The group next examined whether in situations of anoxia leading to 
anaerobic metabolism, succinate dehydrogenase can reverse itself, reducing fumarate to 
succinate(Niatsetskaya et al. 2012; Taegtmeyer 1978) – a concept that has not yet been 
shown in ischemia. It was predicted that fumarate comes to SDH via the malate/aspartate 
shuttle in which the NADH/NAD ratio is high thus forming malate which is eventually 
converted to fumarate;(Hochachka Pw Fau - Storey and Storey 1975; Easlon et al. 2008; 
Barron, Gu L Fau - Parrillo, and Parrillo 1998) and, the activation of the purine-nucleotide 
cycle (PNC) that produces fumarate.(Van den Berghe, Vincent Mf Fau - Jaeken, and 
Jaeken 1997; Sridharan et al. 2008) When the group used the SDH competitive inhibitor 
dimethyl malonate, they saw a sharp decrease in succinate accretion in areas of ischemia 
thus supporting the hypothesis that ischemia drives SDH backwards.(Chouchani et al. 
2014) Moreover, using radio-labelled aspartate, it was found that ischemic tissue 
activates both the malate/aspartate shuttle (MAS) and purine nucleotide cycle (PNC) 
pathways to increase the amount of fumarate that is produced, which in turn is converted 
to succinate by SDH working backwards.  
It was hypothesized that during reperfusion, the accrued succinate becomes 
oxidized by SDH and because the complexes were already hyperactive, reverse electron 
transport becomes driven through complex I.(Hirst, King Ms Fau - Pryde, and Pryde 2008; 
Kussmaul and Hirst 2006; Pryde and Hirst 2011; Murphy 2009) This is compelling,  
because it has been previously shown that succinate can induce RET through complex I 
in cell culture models(Murphy 2009). Using the ΔΨm fluorescent marker TMRM, the group 
discovered that when SDH was inhibited with dimethyl malonate, the membrane potential 
repolarization was significantly abated thus concluding that succinate accumulation in 
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combination with a higher than normal proton motive force leads to RET through complex 
I.(Chouchani et al. 2014)  
Using these findings, Couchani et al. proposed the following model for the role of 
metabolites in IR injury:(Chouchani et al. 2014) When tissue becomes ischemic, fumarate 
increases because the MAS and PNC pathways become active. Fumarate is then 
reduced to succinate when SDH works backwards. When blood flow is restored, the 
excess succinate is quickly oxidized which generates a larger proton motive force due to 
electrons being shunted through complexes III and IV, while simultaneously RET is 
advanced through complex I thus producing ROS. In total these studies demonstrate the 
central role of succinate as a key energy source driving mitochondrial ROS following 
ischemia, with high ΔΨm required to generate and release these deleterious radicals. 
Thus, dephorphorylation of ETC complexes leads to high membrane potential which 
when combined with reversed electron transport leads to the post-reperfusion ROS burst.  
Model of Brain Ischemia/Reperfusion Injury 
Quick restoration of blood flow during brain ischemia is of critical importance; 
however, doing so can exacerbate neuronal injury through the generation of ROS upon 
reperfusion. Having discussed above how the OxPhos complexes function and are 
regulated through reversible phosphorylation, and the role of the mitochondrial membrane 
potential in ROS generation, we are now able to describe a mitochondrial model for 
cerebral reperfusion injury. Because neurons rely nearly entirely on OxPhos, the 
mitochondria of ischemic neurons are starved of their substrate, oxygen; however, 
ischemia itself creates a double-edged sword in which oxygen-starved mitochondria 
become primed for hyperactivation.  
One of the most energy expensive processes in neurons is the maintenance of 
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ionic gradients. Certainly, a high extracellular sodium and a high intracellular potassium 
concentration are critical for neuronal function in the generation of action potentials but 
these are not the only cations that must be carefully regulated by the cell – a difference 
achieved by the sodium/potassium ATPase. When the sodium/potassium pumps fail due 
to the cellular energy failure that occurs during ischemia, ions move down their 
concentration gradients: sodium rushes into the cell and potassium exits until they 
equilibrate across the membrane. This movement of sodium into the cell results in 
depolarization of the cell membrane which opens voltage gated calcium channels. 
Because the concentration of calcium is much higher extracellularly than intracellularly 
(10 mM vs. 0.0001 mM), calcium rushes into the cell. Under normal physiological 
conditions, transient depolarizations and intracellular calcium movement is critical for the 
docking of neurotransmitter-containing vesicles with the membrane and the release of 
their contents into the synaptic cleft; however, in ischemia, calcium accumulates in the 
cytosol, unable to be eliminated by ATP-dependent Ca2+ pumps. Furthermore, 
mitochondrial calcium sequestration through the mitochondrial calcium uniporter (MCU) 
takes place, but under physiological conditions, most calcium is eliminated through 
cytosolic rather than mitochondrial pathways.(Williams et al. 2013) This occurs because 
the MCU affinity for calcium is quite low and requires very high cytosolic calcium 
concentrations for transport of calcium into the mitochondria. In the case of ischemia, due 
to both the failure of the ATPases to remove calcium, as well as the unimpeded movement 
of calcium down its concentration gradient, cytosolic calcium increases.(Bourdillon Pd 
Fau - Poole-Wilson and Poole-Wilson 1981) As intracellular calcium increases, MCUs 
become active and sequester calcium into the mitochondria where it signals several 
deleterious pathways, one of which being programed cell death, which will be reviewed 
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in the following section. 
The increased intermitochondrial calcium concentration activates phosphatases 
that dephosphorylate complexes and proteins, especially cytochrome c and CcO. This 
dephosphorylation leads to the OxPhos complexes being primed for hyperactivation even 
in the absence of the substrate oxygen and leads to a loss of allosteric inhibition by ATP.  
As we have seen, hyperpolarization of the membrane results in exponential ROS 
production.(Liu 1999) Liu et al., and Starkov have clearly demonstrated that once 
membrane potential exceeds just 10 mV beyond the physiological 140 mV, 70 - 90 % 
increases in ROS follow.(Starkov and Fiskum 2002; Suski et al. 2012) Thus, the 
dephosphorylation of OxPhos proteins during ischemia results in enormous ROS bursts 
when reperfusion occurs due to a high membrane potential.  
Once reperfusion is initiated, the deposphorylation of the complexes should serve 
to quickly restore membrane potential leading to the replenishment of ATP. This is 
sensible since deposphorylation causes them to work in overdrive thus reversing any 
depolarization that occurred due to lack of both electrons and the final substrate, oxygen. 
This was convincingly shown by Liu et al. who found that in brain ischemia, when blood 
flow was restored, the membrane potential returned to normal levels within 30 to 60 
minutes.(Liu 1999) However, when allosteric regulation is lost, the membrane potential 
overshoots so to speak and dangerous hyperpolarization ensues. Moreover this has been 
confirmed by cell culture models of ischemia/reperfusion injury.(Iijima et al. 2006) Another 
interesting set of experiments conducted by Choi et al. (2009) found that blockade of 
complex I during reperfusion, halted membrane hyperpolarization and drastically reduced 
ROS formation.(Choi et al. 2009) These findings confirm what was discussed above 
regarding the exponential relationship between ΔΨm and ROS production.  
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Studies looking at global brain ischemia have found that ROS bursts typically occur 
more intensely during the first 15 minutes of reperfusion(Kunimatsu et al. 2011) and these 
ROS have been shown to originate from the mitochondria(Piantadosi and Zhang 1996; 
Fabian, DeWitt Ds Fau - Kent, and Kent 1995; Kudin, Malinska D Fau - Kunz, and Kunz 
2008)– specifically complex I in neurons.(Kudin, Malinska D Fau - Kunz, and Kunz 2008; 
Barja and Herrero 1998; Barja 1999; St-Pierre et al. 2002)  
In conclusion, membrane hyperpolarization due to OxPhos complexes being 
primed for hyperactivation due to changes in their phosphorylation states leads to 
exponential production of ROS during the early stages of reperfusion in brain ischemia. 
Furthermore, as demonstrated by Choi et al, directly targeting the membrane potential 
during reperfusion can have dramatic effects on the amount of ROS produced. Thus, 
modulation of membrane potential can serve as a potential therapeutic strategy for brain 
ischemia/reperfusion injury.  
Delayed Neuronal Death 
Cell death has classically been characterized as either necrotic or apoptotic based 
on morphology. Necrosis, until very recently, was considered an unregulated pathway 
(Proskuryakov, Konoplyannikov Ag Fau - Gabai, and Gabai 2003) although it is now 
believed to arise from converging pathways. Morphologically cells dying by necrosis are 
identifiable by cell membrane rupture and spilling intracellular contents once they have 
been exposed to a stressor that pushes them beyond a threshold of recovery. 
Apoptosis, in contrast, is a cell death paradigm that is executed and is classically 
subdivided into two pathways. Type I (extrinsic) apoptosis is activated either by death 
ligands (by the tumor necrosis factor (TNF) family proteins) that bind to extracellular 
receptors, or by disengagement of life ligands (such as netrin).  Once death ligands bind, 
19 
 
they initiate a series of cell signaling pathways that ultimately result in programmed cell 
death that can either be mitochondrial dependent or not. Type II (intrinsic) apoptosis 
occurs when intracellular signals get transduced to the mitochondria and cause the 
release of apoptogenic factors that lead to apoptosis. Furthermore, the intrinsic pathway 
can be subdivided into caspase dependent and caspase independent mechanisms. 
Caspase dependent apoptosis requires cytochrome c to be released from the 
mitochondria which can involve the formation of the mitochondrial permeability transition 
pore (MPTP) or mitochondrial outer membrane permeabilization (MOMP). Under normal 
conditions a fraction of the cytochrome c pool remains bound to the inner mitochondrial 
membrane lipid cardiolipin. Due to peroxidation of cardiolipin during cell stress (often by 
ROS), cytochrome c dissociates and exits the mitochondria through the MPTP or MOMP. 
Moreover, once released, cytochrome c interacts with the IP3 receptor on the 
endoplasmic reticulum (ER) which causes the ER to discharge calcium into the cytosol. 
Calcium, as we have seen, leads to more cytochrome c release triggering a positive 
feedback loop. Once in the cytosol, Cyt c activates caspase 9 which in turn activates 
caspase 3 and caspase 7, which execute apoptosis. The caspase-independent pathway 
utilizes either the apoptosis inducing factor (AIF) which is released, or failure of the 
electron transport chain. The AIF ultimately induces chromatin condensation and DNA 
fragmentation.  
In ischemia/reperfusion injury, there is evidence to support both pathways of 
programmed cell death playing important roles in death of neurons.(Puka-Sundvall et al. 
2000; Northington et al. 2001) Furthermore, it is the release of apoptogenic factors from 
the mitochondria that seems to initiate the cell death paradigms.(Sanderson et al. 2008; 
Hetz et al. 2005; Cao et al. 2007; Sugawara et al. 1999) Cells that die because of ischemic 
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insults (specifically by delayed neuronal death pathways, not initial hypoxic insults) do so 
in an energy-dependent manner: it requires the expression of new genes; is mediated by 
the caspases; and employs the proteolytic mechanisms of apoptosis.(Dirnagl, Iadecola C 
Fau - Moskowitz, and Moskowitz 1999; Lee, Zipfel, and Choi 1999; Lipton 1999; 
MacManus and Linnik 1997; Schulz, Weller M Fau - Moskowitz, and Moskowitz 1999) 
Ischemic neuronal death is initiated in an programmed manner, beginning first in the 
mitochondria thus triggering cleavage of the caspases leading to destruction of key 
cellular structures and irreversible fraying of the genome, thus leading some investigators 
to term delayed neuronal death as regulated necrosis.  
Fiskum et al. demonstrated that neuronal mitochondria are particularly sensitive to 
energy depletion and respond in turn according to the duration of ischemia.(Fiskum 2000; 
Fiskum, Murphy An Fau - Beal, and Beal 1999) Ouyang et al. found, by observing 
mitochondria in experimental stroke, MTP opening within 1 hour of ischemia;(Ouyang et 
al. 1999) furthermore, Friberg et al. showed that MPT opening corresponded to brain 
areas most sensitive to ischemia.(Friberg et al. 1999)  
Because the mitochondrial membrane permeability to cell death mediators 
increase during ischemia, Fujimura et al. were able to demonstrate that parts of the 
mitochondria, such as cytochrome c, enter the cytosol 4 hours after MCA 
occlusion.(Fujimura et al. 1998) Because of these findings, it tempting to conclude that 
cell death following ischemia occurs according to an apoptotic paradigm, though this is 
not entirely accurate because similar phenotypes can be observed in necrosis as 
well.(Hirsch et al. 2005) At the same time, DNA damage that is observed in brain 
ischemia, while not necrotic, is different than what is seen in apoptosis.(MacManus and 
Buchan 2000; MacManus and Linnik 1997) These results were further corroborated by 
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Colbourne et al. who found no evidence of apoptosis in approximately 40,000 CA1 
neurons that had undergone global ischemia.(Colbourne, Sutherland Gr Fau - Auer, and 
Auer 1999) Furthermore, ischemic neurons differ morphologically from classical 
apoptosis and thus their death cannot be explained by either classical necrosis,  nor 
apoptosis paradigms. (Deshpande et al. 1992; van Lookeren Campagne and Gill 1996; 
Martin et al. 1998; Colbourne et al. 1999; Colbourne, Sutherland Gr Fau - Auer, and Auer 
1999; Ishimaru et al. 1999)  
A significant body of literature has looked at the Bcl-2 group of proteins that 
modulate permeability to cytochrome c and thus delayed neuronal death cascades. Bax 
and Bak seem to be the primary candidates that induce the release of cytochrome c but 
also other pro apopototic proteins like AIF, Smac/Diablo.(Cheng et al. 2001; Kuwana and 
Newmeyer 2003)  
Thus, the question remains how neurons that are ischemic die. For MacManus et 
al. a combination of necrosis and apoptosis might be the answer with necrosis at one end 
of the spectrum and apoptosis on the other.(MacManus and Buchan 2000) These 
correspond to attractor states that Lipton (Lipton 1999) and DeGracia have convincingly 
argued is the most sensible way to approach neuronal death or survival.(DeGracia et al. 
2017) McManus et al. argue that the attractor state, where an ischemic cell ends up is 
dependent upon the severity of the ischemic insult, ATP availability, and both the age and 
location of the neurons.(Dirnagl, Iadecola C Fau - Moskowitz, and Moskowitz 1999)  
Therapies for Ischemia/Reperfusion Injury 
Since free radicals have a deleterious effect on cells following reperfusion, 
eliminating them during early reflow is a critical concern of therapy. Studies have shown 
that following reflow, ROS production greatly surpasses any endogenous antioxidants. 
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To address this issue, a series of clinical trials was undertaken and funded by 
AstraZeneca in the early 2000s which looked at whether a known ROS trapping 
compound, NXY-059, given intravenously following the administration of tPA, would show 
the same neuroprotection in patients as it did in animal models. NXY-059 is a chemical 
derivative of phenylbutylnitrone (PBN). The original Stroke-Acute Ischemic NXY 
Treatment I (SAINTI) trial enrolled 1699 patients and administered either the compound 
or placebo within 6 hours of stroke onset for a 72-hour infusion. The outcome measures 
assigned were based on the modified Rankin scale which assesses the degree of stroke 
disability on a 6 point scale – 0 being no symptoms and 6 corresponding to death. The 
SAINT I trial found that administration of NXY-059 significantly reduced disability three 
months after stroke, but did not improve other outcome measures. The authors concluded 
that additional trials would need to be done.(Lees et al. 2006)  
Soon thereafter the SAINT II trial was conducted which enrolled more patients 
(3306). Like the SAINT I trial, NXY-059 was infused for 72 hours within 6 hours following 
the beginning of stroke symptoms. The primary endpoints as before were disability scores 
on the modified Rankin scale 90 days later and secondary endpoints were scores on 
neurologic and activities of daily living scales. The SAINT II trial found no significant 
difference between NXY-059 and placebo groups for either their primary or secondary 
endpoints.(Shuaib et al. 2007) The authors of SAINT II argue that the false positive 
observed in SAINT I likely occurred by chance, potentially because the first trial included 
patients who went on to develop a poorer progression who were included in the placebo 
group. In any case, intravenous ROS scavenging was shown to be ineffective to treat 
reperfusion injury following acute ischemic stroke. It is likely that these studies failed for 
several reasons: first, rapid delivery of a compound to the tissue is difficult, not only 
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because of vascular occlusions, but also the ability to cross the blood brain barrier; 
secondly the half-life of ROS is extremely short and by the time the compound diffuses 
from the blood, across the plasma membrane, through the cytosol and into the 
mitochondria, the ROS burst is likely over and the damage has been done. Thus, systemic 
antioxidants have not been effective in targeting ROS mediated reperfusion injury. It is 
for this reason that this study has sought, based on the previous work of the 
Hüttemann/Sanderson labs, to limit ROS production rather than scavenge ROS. Here we 
propose that direct targeting of the main mechanism of ROS generation – ΔΨm – can be 
a promising, novel therapeutic strategy and has been shown to be itself protective. (Iijima 
et al. 2006; Pandya, Pauly Jr Fau - Sullivan, and Sullivan 2009; Brennan et al. 2006)  
Conclusions 
This chapter has sought to present a working model for ischemia/reperfusion injury 
based on the role of the mitochondria in generating ROS during early reflow. Our group 
has demonstrated support for this model in previous works. We hypothesize that 
mitochondrial membrane potential hyperpolarization is directly responsible for ROS 
production, which in turn causes oxidative damage to the cell and initiates delayed 
neuronal death pathways. We argue that ischemia leads to post-translational modification 
of OxPhos complexes, primarily dephosphorylation, due to calcium-mediated activation 
of endogenous phosphatases. This leads to a loss of allosteric regulation and priming of 
ETC enzymes for hyperactivity and membrane hyperpolarization when the substrate, O2, 
is restored during reperfusion. Because of the membrane potential hyperpolarization 
when oxygen does return, ROS is quickly and exponentially generated by complexes I 
and III which inundates any endogenous antioxidants, damages the cell, and activates 
delayed-neuronal death cascades. Furthermore, ROS scavenging has been shown to be 
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ineffective in targeting this ROS, likely due to the inability to deliver adequate doses to 
sub-cellular compartments, in particular the mitochondria, quickly enough. However, our 
model opens the door for the development of a novel therapeutic strategy that targets the 
membrane potential itself thus eliminating the need for ROS scavenging and stopping its 
production at its source.   
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CHAPTER 2 - MITOCHONDRIAL MODULATION BY NEAR-INFRARED LIGHT IN 
BRAIN ISCHEMIA  
Introduction 
Brain ischemia is a major cause of death and disability globally. As was outlined in 
detail in Chapter 1, because neurons are both metabolically demanding, and rely almost 
entirely on oxidative phosphorylation to meet these energy demands, any disruption in 
the delivery system of oxygen and metabolites to brain tissue has dire consequences. 
Blood flow can be disrupted to the brain in three primary pathologies. First, global brain 
ischemia occurs when systemic arterial pressure falls below the ability of the brain’s 
autoregulatory system to maintain adequate cerebral perfusion. This occurs most 
commonly during cardiac arrest when cardiac output plummets and, since, it is systemic 
pressure that falls, neither the usual anatomic nor physiological mechanisms can ensure 
blood flow to the brain and thus the entire brain experiences ischemia. Brain regions that 
are most susceptible to death following global brain ischemia are the CA1 region of the 
hippocampus as well as areas that lie between the distal ends of two collateral vessels. 
Known as watershed zones, these areas heavily rely on adequate perfusion pressure 
through the collateral vessels to receive blood. Furthermore, it has been noted that brain 
damage following cardiac arrest/resuscitation leading to global brain ischemia results in 
three processes: 1) most structural damage is seen during the reperfusion phase and not 
during the initial ischemia; 2) cortical pyramidal neurons in layers III and V and the CA1 
and CA4 hippocampus are most sensitive and display what is known as “selective 
vulnerability”; 3) during reperfusion, these selectively vulnerable neurons demonstrate a 
sustained reduction to synthesize new proteins.(White et al. 1996)  Like global brain 
ischemia, several pathologies taking place following birth can induce brain ischemia in 
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neonates resulting in neonatal hypoxic-ischemia encephalopathy. Finally, relevant to this 
study, focal brain ischemia occurs when a limited region of the brain becomes ischemic 
due to the occlusion of a blood vessel. In all three cases of brain ischemia, quickly 
restoring blood supply is crucial for saving neurons and preventing further brain damage. 
However, as was outlined in detail in Chapter 1, restoration of blood flow results in the 
generation of mitochondrial ROS due to mitochondrial membrane hyperpolarization that 
go on to further damage cells in a pathology known as reperfusion injury. Thus, to 
effectively treat reperfusion injury, ROS must be reduced as quickly as possible. As we 
described previously, pharmacological approaches have been unsuccessful in achieving 
this goal.  
These approaches for reducing ROS have largely been ineffective likely due to a 
combination of factors including the inability of compounds to reach brain tissue via the 
blood stream when an artery is occluded; as well as the difficulty in getting compounds 
into sub cellular compartments fast enough following the initial ROS burst within the first 
seconds to minutes following reperfusion. It has thus been the goal of our laboratory to 
develop a non-invasive therapy that can be applied immediately upon reflow and reduce 
the amount of ROS produced rather than scavenging them. Our approach has been to 
use infrared light (NIR) which, unlike other wavelengths of the visible light spectrum can 
easily penetrate tissues within a range of 700-1000 nm and thus can target deep cellular 
structures. 
Modulating Mitochondrial Activity Using Near Infrared Light  
Near-infrared light has been shown to be beneficial and to influence the 
mitochondria(Yu 1997; Yeager 2005; Wong-Riley et al. 2005; Streeter 2004; Eells 2004, 
2003; Wong-Riley 2001). Furthermore, it has shown promise in regenerating nerves, 
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stroke, peripheral neuropathy and wound healing.(Wong-Riley et al. 2005; Whelan 2003; 
Leonard 2004; Bae 2004; DeLellis 2005; Lim 2009; Lapchak 2007; Oron 2006; 
Detaboada 2006; Lapchak 2004) However, results have been inconsistent at best. The 
contradictory nature of the results is likely due to a limited understanding of how NIR 
exerts its action upon cell function.  
Cytochrome c oxidase (CcO) is the terminal enzyme in the electron transport chain 
and the proposed rate limiting step of the entire reaction. The dimeric enzyme is 
comprised of 13 subunits per monomer and is regulated, as we previously described, by 
post translational phosphorylations, and the ATP/ADP ratio which in healthy cells adjusts 
energy production to energy demand. It is widely accepted that CcO is the primary 
photoreceptor of NIR. The enzyme is composed of chromophores that include two copper 
centers that are involved in enzymatic action and have been shown in previous studies 
to be the sites of photoreception of NIR.(Karu 1999; Karu and Afanas'eva 1995; Mason 
2014) Copper broadly absorbs light in the near NIR range of wavelengths (700 to 1000 
nM).(Hazeki O 1988; Griffiths DE 1961; Wharton DC 1964) The Hüttemann lab used 
N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD) which is an electron transport 
catalyst that alters the phase of CcO kinetics from biphasic to monophasic in order to gain 
mechanistic knowledge of how NIR affects CcO.  Unlike in vivo where cytochrome c 
associates and dissociates from CcO, in the presence of TMPD, cytochrome c stays 
bound to CcO while the compound itself shuttles electrons to cytochrome c from 
ascorbate which is a reductant thus eliminating the need for cytochrome c to bind and 
then dissociate from CcO.  It was found that in the presence of TMPD, the inhibitory effect 
of NIR is significantly reduced and thus it is hypothesized that the inhibitory wavelengths 
affect the binding of CcO with cytochrome c at the CuA center of CcO next to the 
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cytochrome c binding site. Despite these insights, detailed understanding of the 
mechanism of how NIR can modulate the activity of CcO is not yet fully understood.  
Many studies have shown that NIR can activate CcO.(Wong-Riley 2001; Wong-
Riley et al. 2005; Yu 1997; Yeager 2005; Streeter 2004; Eells 2004, 2003)  For example, 
applying wavelengths of 670 nm and 808 nm increased CcO activity and in turn overall 
mitochondrial respiration,(Wong-Riley et al. 2005; Pastore, Greco, and Passarella 2000) 
and the Hüttemann lab has shown that this holds true for one wavelength (810 nm). This 
was tested on isolated CcO enzyme from cow liver  and pig brain (unpublished), in which 
four wavelengths were discovered that show CcO inhibition for the first time after 
scanning the near NIR range between 700-1000 nm: 750, 870, 910, 950 nm.(Sanderson 
et al. 2018) This range was chosen because it is classically considered the “therapeutic 
window of opportunity” because NIR absorbance by other biological compounds like 
blood and water are minimal. Using a light-protected oxygen electrode chamber that was 
combined with a double beam spectrophotometer, isolated and purified CcO was 
subjected to the wavelengths of NIR and its activity measured. It was later shown that 
CcO activity can also be optimally inhibited by two wavelengths of NIR, specifically 750 
nm or 950 nm, and this effect is compounded when the wavelengths are 
combined.(Sanderson et al. 2018)  
Next, the Hüttemann/Sanderson laboratories isolated mitochondria in order to 
measure the effect of NIR on mitochondrial respiration.(Sanderson et al. 2018) It was 
found that applying the inhibitory wavelengths reduced respiration by 24-25% while the 
excitatory 810 nm wavelength increased respiration and thus overall oxygen 
consumption. When the inhibitory wavelengths were combined (750 + 950 nm), 
respiration was reduced by 34 %.   
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NIR Proposed Mechanism in Reducing ROS 
As was described in chapter 1, the ETC transfers electrons to oxygen, a reaction 
that is the rate limiting step(Villani 1997; Kunz 2000; Acin-Perez 2003; Piccoli 2006; 
Dalmonte 2009), catalyzed by cytochrome c and CcO. As electrons pass through 
complexes I, III, and IV, protons are simultaneously pumped across the inner 
mitochondrial membrane, into the intermembrane space. The action of transferring these 
protons generates the mitochondrial membrane potential (ΔΨm) which is a measure of 
the difference in electrical potential across the membrane. Moreover, as described in 
detail in Chapter 1, reperfusion hyperpolarizes the membrane, increasing ΔΨm, and 
inducing an exponential increase in ROS production. Therefore, it stands to reason that 
any action enacted on the rate limiting step, cytochrome c/CcO, can either speed up or 
slow down the entire reaction. Moreover, direct modulation of CcO with NIR, may allow 
for controlling ΔΨm and thus ROS production.  
To interrogate this hypothesis, the Sanderson laboratory used live-cell imaging 
with the ΔΨm fluorescent probe, TMRM.(Sanderson et al. 2018) They found that 
irradiating the cells with NIR with the 950-nm wavelength, decreased the membrane 
potential which rapidly returned to basal levels when the light was no longer applied. Next, 
NIR was tested in an in vitro model of ischemia reperfusion injury. Using immortalized 
hippocampal cells (HT22 neurons), it was discovered that the mitochondrial membrane 
potential is indeed hyperpolarized during the first 30 minutes following reperfusion. 
Moreover, irradiation of the cells with the inhibitory NIR reduced the membrane potential.  
Next, the group examined the survivability of neurons that were given NIR 
treatment following oxygen-glucose deprivation.(Sanderson et al. 2018) Cells received 
NIR treatment via fiber-optic light guides for an hour following reoxygenation and the 
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number of cells that died were quantified using a Live/Dead viability assay 24 hours later. 
Fewer cells died when treated with inhibitory NIR wavelengths (750 nm and 950 nm). In 
contrast the excitatory wavelength of (810 nm) did not save cells.  
NIR Reduced ROS Production in CA1 Hippocampal Neurons Following Reperfusion 
Next it was necessary to show that CcO is hyperactive following 
ischemia.(Sanderson et al. 2018) To interrogate this hypothesis, brains were harvested 
after 8 minutes of global ischemia followed by reperfusion. CcO specific activity was 
measured and a significant increase in activity was observed in brain tissue during 
ischemia and reperfusion compared to non-ischemic controls. It is hypothesized that 
these changes cause membrane hyperpolarization in vivo as shown previously.(Liu, 
Fiskum G Fau - Schubert, and Schubert 2002) In order to confirm this theory, ROS 
production was quantified using MitoSOX fluorescence, which detects mitochondrial 
superoxide production. Following 8 minutes of brain ischemia and 30 minutes of reflow, 
a seven-fold increase in MitoSOX fluorescence was observed in CA1 hippocampus, 
indicating an accretion of ROS in these neurons. Consistent with our hypothesis, 
irradiation with CcO-inhibitory NIR showed MitoSOX fluorescence similar to the sham-
surgery control groups, suggesting that CcO-inhibitory NIR treatment can prevent ROS 
formation.  
NIR Therapy Given at the Onset of Reperfusion Reduces CA1 Hippocampal 
Neuronal Death Following Global Brain Ischemia/Reperfusion  
The first in vivo study of the neuroprotective efficacy of NIR was performed in the 
rat global ischemia model following bilateral carotid occlusion with 
hypotension.(Sanderson et al. 2013) As described above, neuronal death occurs 
predominantly in the CA1 hippocampus in this model. These neurons are particularly 
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sensitive to this insult and a near total loss of CA1 hippocampal neurons can be seen 3-
7 days following reperfusion. In our study, untreated controls showed a significant loss of 
CA1 hippocampal neurons after 14 days (88%) as measured by cresyl violet staining and 
neuN fluorescent neuronal markers. Furthermore, gliosis was seen, characterized by 
immune responses; particularly inflammatory cells entering the area. 
Ischemia/reperfusion injury induced the translocation of microglia and macrophages as 
well as astrocytes, all seen in the CA1 hippocampus using confocal microscopy.  
Animals treated with CcO-inhibitory wavelengths of 750nm and 950 nm, either 
alone or combined, showed significant reductions in hippocampal neuronal death.  
Animals treated with the NIR inhibitory wavelengths only had 11 to 35 % of their CA1 
hippocampal neurons die. As predicted, the CcO-excitatory wavelength of 810 nm did not 
improve the survivability of these neuron populations.(Sanderson et al. 2018) 
NIR Therapy Reduces Brain Injury in Neonates Following Simulated Hypoxia 
Approximately 0.002-0.004% of at-term hospital births result in the neonatal brain 
becoming hypoxic which leads to a condition known as hypoxic-ischemic encephalopathy 
(HIE). This pathology can cause long-term health issues such as cerebral palsy or 
epilepsy.(Al-Macki 2009) A number of factors can contribute to HIE such as maternal 
hypotension; however, the most common cause is compression of the umbilical cord or 
prolapse and placental abruption. Moreover, neonatal brains are also susceptible to 
reperfusion injury. Unpublished work from our laboratory has shown that in the Vinucci-
Rice model of HIE, the inhibitory NIR wavelength of 750 nm reduced brain injury due to 
hypoxia-ischemia in neonates – a finding that is consistent with the global ischemia 
model. Moreover, inhibitory NIR applied at the onset of reperfusion reduced caspace-3 
cleavage thus stopping cells from undergoing programmed cell death.(Reynolds 2015)  
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Conclusion 
Both the published and unpublished data from the Hüttemann/Sanderson 
laboratories provide evidence for our model of IR injury in which transient reductions in 
mitochondrial membrane potential during reperfusion can reduce ROS production, which 
is the number one cause of neuronal death in IR injury. (Mason 2014; Hazeki O 1988) As 
was described in chapter 1, the relationship between ROS and ΔΨm is exponential – when 
the membrane potential exceeds 140 mV due to hyperactivation of the complexes, ROS 
increases exponentially. We thus argue that even moderate reductions in membrane 
potential can enact an exponential decreases in ROS production. This was first shown in 
HT22 cells in which we showed that inhibitory NIR reduces CcO activity. When the same 
wavelengths were applied immediately upon reperfusion in an in vivo rat model of global 
brain ischemia, we saw significant reductions in CA1 hippocampus neuronal death which 
was corroborated by behavioral improvements as measured by memory and spatial 
learning tasks. Moreover, similar results were seen in a neonatal model of brain 
ischemia/reperfusion. Thus, in two animal models, NIR has been shown to reduce ROS 
production in early reperfusion by directly targeting the rate limiting enzyme of the ETC, 
CcO, reducing its activity and thus reducing overall ΔΨm. 
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CHAPTER 3 - MAGNETIC RESONANCE IMAGING IN STROKE RESEARCH AND 
IAGNOSIS  
MRI Fundamentals 
A series of elegant experiments in 1938 by Isidor Rabi first performed in gas beams 
revealed a unique principle of matter: magnetic resonance.(Rabi et al. 1938) In 1973, 
Paul Lauterbur published the first magnetic resonance image in Nature.(Lauterbur 1973) 
He placed two 1-mm tubes of water in a 1.4 T magnet and when he applied magnetic 
field gradients rotating by 45 degrees, he was able to produce four, one-dimensional 
projections of the signal. When working backwards, these images were then able to 
produce a 2-dimmensional image.   
Physiologically, water is the most abundant compound in the brain followed next 
by lipids, both of which are heavily comprised of protons which can generate an MRI 
signal and they have a mass, a charge (positive), and a spin. Spin, in the case of 
subatomic particles, is an intrinsic component of the proton, which means that it is 
independent of any external force, causing the particle to spin like a top along an axis 
with a wobble. Furthermore, spin on an individual proton is ½ Plank’s constant. Thus, the 
combination of the charge and spin means that protons have a nuclear magnetic moment, 
which is defined as a nonzero magnetic dipole. Thus, protons rotating on an axis generate 
a small magnetic field. However, it must be noted that at room temperature they are 
randomly oriented with their spins being either -1/2 or +1/2 and as a result, there is no net 
magnetization – body tissues, for example, are not magnetic.  
If a tangential force is applied along the z-axis the proton wobble increases. This 
force, in MRI, is generated by a radio-frequency (RF-pulse) which is time-dependent 
sinusoidal wave that matches the precessional, or Larmor frequency of the protons. It is 
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critical that the RF pulse matches the Larmor frequency because the key is to generate 
resonance strong enough to push the protons into the transverse rotational plane. 
Applying an RF pulse at a proton’s Larmor frequency causes its net magnetization (M) to 
flip and rotate into the transverse magnetization. Due to Faraday’s law of electromagnetic 
induction, any magnetic field can interact with an electric circuit to produce an 
electromotive force. Thus, as protons begin rotating in the transverse plane due to their 
spins being flipped 90 degrees by the RF pulse, they induce a current each time they spin 
through the copper receiving coil. Thus, the current signal that is produced encodes the 
Larmor frequency. Since the protons composing different tissues, fat, bone, muscle, etc. 
have different precessional frequencies due to the atomic composition of the tissue itself, 
frequency encoding can differentiate the tissues based on the RF pulse applied.  
MRI in Stroke 
Brain imaging in cases of acute stroke provides critical information to clinicians 
regarding stroke severity and location in a timely manner, thus allowing physicians to 
quickly determine whether the patient is a candidate for receiving fibrinolytic therapy. Prior 
to initiating this treatment, other pathologies such has cerebral hemorrhage must be ruled 
out. To date, computed tomography (CT) imaging is still the best approach for 
differentiating hemorrhagic from ischemic stroke. However, due to the requirement for 
systemic administration of a radioactive contrast agent, as well as low sensitivity in 
detecting ischemic lesions, it remains suboptimal. Many studies since the early 1990’s 
have provided convincing evidence that MRI is a far superior imaging modality for use in 
diagnosis of acute ischemic stroke.(Baird and Warach 1988; Barber et al. 1998; 
Schellinger et al. 2001; Tong et al. 1998) In what follows we shall review in greater detail 
the most common and useful MRI modalities both in the clinic and in the utilization in this 
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study.  
Diffusion Weighted Imaging (DWI) 
In 1905, Albert Einstein published a paper in which he refined the theory of the 
Scottish-born botanist, Robert Brown to describe the apparent movement of molecules 
suspended in a liquid due to the molecular-kinetic theory of heat.(Einstein 1905) If a drop 
of ink were to be added to a beaker of water, the ink atoms would diffuse throughout the 
beaker seemingly, though, because the diffusion is unimpeded, the probability of finding 
any particle of ink, according to Einstein, can be predicted using a diffusion coefficient 
that is related to the mean square displacement of the Brownian particle, where, the mean 
square displacement reflects the derivation of the particle’s position with respect to a 
certain position over a given period of time.(Michalet 2010) Thus, diffusion maps can be 
generated in Euclidean space comprised of a set of coordinates that were determined 
from the eigenvalues and eigenvectors of the diffusion constant.(Coifman and Lafon 
2006; Coifman et al. 2005)  
Within most fluids diffusion is even, as we saw in the example of the ink in the 
water, which results in equal diffusion of particles in all directions across time. This is 
called isotropic diffusion and defined with a single diffusion coefficient. Biological tissues, 
however, present a myriad of impediments to free diffusion and thus result in a number 
of diffusion coefficients in multiple directions. This behavior is known as anisotropy, where 
diffusion must be described by a 3 x 3 matrix known as the diffusion tensor. The nervous 
system in particular is highly anisotropic due to the presence of cell membranes and 
myelination, both of which are highly hydrophobic and thus impede the free diffusion of 
water.(Beaulieu 2002) 
During brain ischemia, cessation of blood flow has a direct effect on the ionic 
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gradients. Hossmann et al.  performed a key set of experiments in which they recorded 
the activity of extracellular sodium and subarachnoid sodium ions using ion-sensitive 
electrodes. During ischemia, they found extracellular [K+] increases from 3.3 to 56 mEq 
per liter and [Na+] decreases from 133 to 53 mEq per liter. Following reperfusion, ionic 
distribution gradually returned to physiological levels within an hour. Most notably, they 
found that the intracellular uptake of sodium was accompanied by a water shift into the 
intracellular compartment which resulted in shrinking of the extracellular space from 18.9 
to 8.5 vol%.(Hossmann Ka Fau - Sakaki, Sakaki S Fau - Zimmerman, and Zimmerman 
1977) Because acute stroke leads to rapid reductions in the OxPhos capabilities of the 
cell, ATP stores plummet and lactic acid accumulation increases which leads to failure of 
the Na+/K+-ATPase. As Hossmann found, pump failure causes ions to equilibrate across 
the neuronal membrane following their concentration gradients. This in turn leads to a 
shift of fluid into the cell. Furthermore, these processes occur in a matter of minutes 
following ischemia.(Hossmann Ka Fau - Sakaki, Sakaki S Fau - Zimmerman, and 
Zimmerman 1977; Moseley, Kucharczyk J Fau - Mintorovitch, et al. 1990)  The reduction 
of the extracellular space by about 55% increases the anisotropy of ischemic brain tissue 
thus trapping water molecules between membranes that were previously free to diffuse 
along membranes. Using strong magnetic field gradient strengths (b values of 1413 
s/mm2), Moseley et al. found that, in MCA occluded cats, DWI signal strength showed a 
significant hyperintensity following 45 minutes of ischemia that was not seen in other 
imaging modalities such as T2 weighted imaging (T2WI).(Moseley, Cohen Y Fau - 
Mintorovitch, et al. 1990) Thus, as water becomes more impeded during ischemia, DWI 
signal intensity increases.  
However, the question then arises, does DWI show actual cell death or just 
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edema? Sodium ion influx into the cell following ATP reduction also leads to chloride influx 
through the chloride channels leading to an increase in osmolality that favors water to 
shift inward through the aquaporin channels.(Badaut et al. 2001; Badaut et al. 2002; 
Kimelberg 2004; Moseley, Cohen Y Fau - Mintorovitch, et al. 1990) As the intracellular 
fluid volume increases and the extracellular space decreases, alterations form in 
membrane architecture resulting in blebbing. Thus, when the  ionic pumps fail, the cell 
dies via a process known as oncosis,(Weerasinghe and Buja 2012) first coined by von 
Recklinghausen.(Szabo 2008) Furthermore, oncotic death can be morphologically 
characterized by damage to membrane phospholemma and organelle membranes, as 
well as loss of phospholipids and the eventual disappearance of nuclei.(Barros, Castro J 
Fau - Bittner, and Bittner 2002; Barros, Hermosilla T Fau - Castro, and Castro 2001; 
Majno and Joris 1995) Thus, cellular edema in brain is definitively cytotoxic and therefore 
a positive DWI signal indicates very early on the extent of neuronal infarction plus 
edema.(Liang et al. 2007) It is important to clarify that the early time point shows edema 
in addition to ischemic cell death because infarct sizes become smaller when measured 
by T2 weighted imaging during the chronic phase of stroke.  
The quantification of impedance of water is known as the apparent diffusion 
coefficient (ADC), which is calculated by software and reflects the degree of diffusion of 
water within the tissue under examination.(Schlaug et al. 1997) The higher the ADC 
value, the more freely water diffuses and therefore the brighter the area on the image. An 
ischemic lesion that has restricted diffusion of water due to the death of cells will have a 
lower ADC and thus appear hypointense.(Baird and Warach 1998)  
In addition to the ADC, another important variable in DWI is the b value. The b-
value is a measure of the strength and duration of the field gradients: the higher the b 
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value, the more powerful the diffusion weighting and thus the more accurate the imaging 
of diffusion effects.(Stejskal and Tanner 1965; Kingsley and Monahan 2004; Burdette et 
al. 2001) In this modality, acute stroke appears hyperintense to surrounding tissue.  
In conclusion, though initially shown in animal models that DWI can become 
positive as early as 5 minutes into ischemia, this occurs 2 to 6 hours after the onset of 
symptoms in humans. (Reith et al. 1995; Back et al. 1994; Sevick et al. 1992; Perez-
Trepichio et al. 1995; Marks et al. 1996; Sorensen et al. 1996; Warach, Dashe Jf Fau - 
Edelman, and Edelman 1996) The ability to detect lesions is certainly an advantage of 
DWI but it is not the only one: other assets to the technique include low false negative 
rates (5%)(Singer et al. 1998) and it is also able to clearly delineate between ischemic 
and non-ischemic parenchyma(Lutsep et al. 2004; Marks et al. 1996; Koroshetz Wj Fau 
- Gonzalez and Gonzalez 1997), and the ability to differentiate acute and chronic ischemic 
zones.(Lutsep et al. 2004; Singer et al. 1998) Thus, it has been shown clinically that DWI 
is far superior to other imaging modalities in detecting early strokes and shows a high 
correlation between stroke lesion volume and clinical outcome. (van Everdingen et al. 
1998)  
T2-Weighted Imaging  
T2 weighted imaging relies on the transverse relaxation, also known as “spin-spin” 
relaxation of the magnetization vector. Once the RF pulse inverts the proton spins, they 
begin to relax away from the transverse plane to the longitudinal one. While this is 
happening, the spins deteriorate from their position in the transverse plane and the 
amount of time of decay reflects the T2. The amount of time it takes for each proton to 
undergo T2 decay depends on inherent properties of the tissues but also its magnetic 
susceptibility.   
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The T2 sequence is comprised of the following imaging characteristics that equip 
the modality for imagining of the brain in both its physiological and pathological states. 
The T2 signal increases (appears brighter) when there is greater water content, such as 
in cases of edema, tumors, infarction, and infections. Blood also appears bright as does 
cerebral spinal fluid (CSF). The reason why these compounds appear brighter is because 
they have a longer transverse relaxation time, or a faster relaxation time.  In pure water, 
the T2 is very long, on the order of 3-4 seconds because unimpeded water moves faster 
than the Larmor frequency. As protons become more constrained in larger molecules, the 
relaxation time shortens because the motion of the protons slows down. A shorter 
relaxation time means that the protons stay for a shorter amount of time in the transverse 
plane before returning to their net magnetization position and thus produce a darker 
image. As the amount of water in a tissue decreases, such as in cases of bone or soft 
tissue, the signal is lost more quickly and the image appears darker in those areas. (Allisy-
Roberts and Williams 2008; Mitchell Dg Fau - Burk et al. 1987) 
In stroke, T2 lesions appear as bright, hyperintense regions that become positive 
in humans within the first 3-8 hours after the onset of ischemia.(Mohr et al. 1995) N van 
Bruggen et al. found that, consistent with previous findings, cerebral edema is accurately 
identified by T2WI which they corroborated histologically by tracing the localization of a 
tracer protein. (van Bruggen et al. 1992) Interestingly, there is a lag time before T2 
becomes positive, with T2 becoming positive more chronically and DWI more acutely.(van 
Bruggen et al. 1992) For this reason, both imaging modalities are commonly used 
clinically: DWI very early in the course of stroke to identify lesions quickly, and T2WI to 
track chronic lesions.(Powers et al. 2018)  
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Perfusion Weighted Imaging  
Measuring cerebral perfusion both during ischemia and reperfusion provides 
important information on the extent of tissue that is at risk for infarction in the absence of 
intervention. Tracking the movement of blood through the brain’s vasculature can be 
accomplished by several imaging modalities, most notably CT angiography (Knauth et al. 
1997; Shrier et al. 1997) and gadolinium based MRI.(Merten et al. 1999) In what follows, 
arterial spin labeling (ASL) MRI will be discussed as a viable alternative to both these 
techniques. 
Arterial Spin Labeling Perfusion MRI (ASL) 
Arterial spin labeling is an MRI modality that uses arterial blood as an endogenous 
contrast to measure perfusion thus eliminating the need for injecting contrast agents or 
tracers.(Alsop and Detre 1995; Buxton et al. 1998; Rosen et al. 1990; Detre et al. 1994; 
Wolf and Detre 2007; Petersen et al. 2006; Alsop and Detre 1998; Williams et al. 1992; 
MacIntosh et al. 2010; Liu and Brown 2007; Wong et al. 2006; Golay, Hendrikse J Fau - 
Lim, and Lim 2004; Wu et al. 2007; Zhang et al. 1995; Barbier, Lamalle L Fau - Decorps, 
and Decorps 2001; Detre et al. 1992) The technique works as follows: first, the computer 
obtains control images of an area of interest. Following this, radio frequency pulses are 
applied to an area that is upstream from the region of interest that invert the magnetization 
of the protons composing water within this slab (usually in the neck). These inverted 
protons which are magnetically labeled can flow into the region of interest where they mix 
and displace their magnetization to the unlabeled water thus slightly reducing the 
equilibrium magnetization in the region of interest. The region of interest is imaged once 
more and the tagged images are subtracted from the control images. Because the labeled 
water molecules freely cross from capillaries into extracellular space and even enter cells, 
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perfusion rates can be calculated.  
ASL can be further subdivided into continuous ASL (CASL) and pulsed ASL 
(PASL). CASL, first proposed by Williams et al. in 1992,(Williams et al. 1992) involves 
continuous radiofrequency labeling through a narrow slice of the neck. Magnetization is 
inverted by the dual application of a continuous pulsed RF for two to four seconds and a 
magnetic field gradient oriented in the direction of blood flow.(Ferré et al. 2013) An 
advantage of using CASL is that it has higher contrast.(Wang et al. 2002) However, 
notable disadvantages are the high magnetization transfer (MT) and the high level of 
energy that is applied to the tissue.(Ferré et al. 2013)  
PASL, in contrast uses very short RF pulses over larger areas.(Ferré et al. 2013) 
Symmetrical PASL uses the flow alternating inversion recovery (FAIR) method in which 
a non-descript pulse that inverts the protons is applied during the control phase that 
eventually becomes selective when a slice-selection gradient is applied during the 
labeling phase.(Kim 1995) The asymmetrical methods, which are the ones employed in 
this study, involve what was described above: a labeling zone with a 10-15 mm thickness 
that is located away from the region of interest that is subtracted from a control image. 
(Edelman et al. 1994) 
The goal of perfusion imaging in the context of acute stroke is to identify 
hypoperfused tissue (penumbra) and to differentiate it from the ischemic core.(Parsons 
et al. 2010; Bivard et al. 2011) The usefulness of perfusion weighted imaging lies in both 
its ability to track cerebral blood flow within a specific volume of tissue per unit time and 
thus an ischemic threshold can be set; but also, volumetric analysis can be performed on 
gross tissue to determine the ratio between at-risk and infarcted tissue – this is known as 
the perfusion/diffusion mismatch and will be outlined in greater detail below.  
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Perfusion/Diffusion Mismatch 
Identifying tissue that has the potential to be salvaged by conventional stroke 
therapies is paramount in the clinical setting. Ischemic stroke zones, as we have 
previously seen, can be broadly defined as core and penumbra. The core is classically 
defined as the area of brain most proximal to the occluded vessel containing neurons that 
rapidly undergo energy depletion, anoxic depolarization and death following a necrosis 
morphology; unfortunately, nothing can be done to salvage these neurons. Surrounding 
the ischemic core is an area of brain that receives enough blood flow from collateral 
vessels that maintains neuronal viability even in the absence of their electrical activity. 
This area has been termed the penumbra and if left untreated eventually goes on to die 
via a delayed neuronal death program. Thus, restoration of blood flow through tPA or 
thrombectomy in a timely manner is of critical importance to save penumbral neurons. 
However, as we previously described, the very same intervention designed to save them 
can result in their downfall following reperfusion; though ROS is only one component of 
the injury mechanism.   
Since the ischemic brain is not homogenous but is comprised of different zones of 
viability and activity according to collateral flow rates, it stands to reason that they can be 
imaged, in vivo, and conclusions drawn regarding the extent of the ischemia as well as 
the potential for saving the penumbra.  
In any given area of ischemic brain, PWI hypointensities can be defined as an area 
that is at risk for infarction and DWI hyperintensity as already infarcted tissue. It was thus 
theorized that a volume for volume mismatch exists between at-risk and infarcted tissue 
or PWI and DWI on MRI modalities during the early phase of ischemia – a mismatch that 
eventually grows smaller as the infarcted area grows larger over time due to either lack 
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of intervention or reperfusion injury. Thus, the difference between PWI and DWI during 
ischemia reflects potentially salvageable brain tissue. Some of the most compelling data 
to the validity of the mismatch are that eventually diffusion abnormalities grow into the at-
risk area. For example, in clinical studies that enrolled patients in neuroprotective 
therapies it was shown that lesions on average grow from 144% to 180% from their initial 
volume across time. Patients who were reperfused within clinically relevant time windows 
had diffusion abnormalities stop growing which may suggest that the mismatch area was 
salvaged. This was shown convincingly by Jansen et al.(Jansen O Fau - Schellinger et 
al. 1999) Further corroborating these results, Parsons found that tPA treated patients had 
higher mismatches than untreated controls – a finding which suggests that more at-risk 
tissue was salvaged due to reperfusion.(Parsons et al. 2002) Interestingly, the PWI/DWI 
mismatch may occur in patients as late as 24 hours and even later from the onset of 
symptoms. Darby et al showed that while mismatch decreased across time, around 60-
70% of patients still had significant mismatches as late as 24 hours. (Darby et al. 1999) 
It must be noted, however, that the PWI/DWI mismatch, at least according to 
Kidwell et al, is based on two fundamental assumptions. First, the boundary of PWI 
hypointensity that is seen delineates between the penumbra and healthy tissue. Second, 
the boundary between PWI and DWI regions reflects the core. In what follows, 
shortcomings of the PWI/DWI mismatch will be described in greater detail.  
The primary criticism of this theory is that it is not easy to differentiate between true 
penumbra and benign oligemia. The initial Astrups study found that rather than two clearly 
defined regions of core and penumbra, there is an additional, third zone in which blood 
flow falls below physiological levels but the tissue is at no time at risk for infarction. 
Astrups defined these regions according to the amount of blood flow received per 100 
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grams of tissue per minute. Core flow rates fell between 6 and 10 ml/100g/min. Penumbra 
values fall between 10 and 20 ml/100g/min. While this criticism is valid, it still does not 
explain how infarction volumes eventually expand into the at-risk volume if left untreated.  
Conclusions 
Multi-modal MRI has developed into the gold standard for stroke diagnosis and 
treatment in the clinic. The ability to image the brain in real-time across a number of 
parameters can give clinicians up to date information on the extent of brain injury as well 
as the amount of tissue that can be salvaged by any therapeutic intervention. Perfusion-
weighted MRI is a powerful tool that gives insight on both relative cerebral perfusion rates 
within a voxel of tissue or across slices, as well as the volume of hypoperfused tissue. 
Diffusion weighted imaging can give an early assessment of infarcted brain tissue as well 
as be a powerful predictor of final infarct size which can be computed in the chronic phase 
of stroke by T2 weighed imaging. This project has employed all of these MRI modalities 
in order to increase the translatability of our findings, as well as to track real-time, in vivo 
changes in infarct progression in individual animals.  
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CHAPTER 4 - INFRARED LIGHT THERAPY AS A NOVEL TREATMENT FOR 
STROKE: TWO TREATMENT WINDOWS 
Introduction  
Stroke is one of the leading causes of death and disability in the Western world 
and accounts for approximately 1 in 20 deaths in the United States.(Benjamin et al. 2017)  
Ischemic stroke occurs due to the occlusion of an intracranial artery resulting in rapid and 
cytotoxic reductions in blood flow to the brain parenchyma. Classically, neurons directly 
affected by the occlusion have been divided into two groups: the ischemic core and the 
penumbra. The core contains neurons that are closest to the occlusion which suffer rapid 
energy depletion, ionic equilibration, and irreversible necrosis. Surrounding the core is 
the penumbra which is a region that has increasing rates of perfusion moving outwards 
because it is fed by collateral vessels, and as such remains ischemic yet viable. 
Therefore, stroke therapies aim at reducing the size of the core and salvaging the 
penumbra. Moreover, MRI modalities are becoming the gold standard for identifying 
potentially salvageable brain tissue.  
To date, the only approved treatment is rapid restoration of blood flow either 
pharmacologically with tPA or surgically with a thrombectomy. While patient outcomes 
have greatly improved due to these early interventions, a substantial amount of tissue 
damage occurs during the reperfusion phase. As the ischemic brain tissue is re-
oxygenated, ROS are quickly generated, beginning at the early stages of reflow which 
goes on to cause further cell death by way of complex, interacting molecular pathways. It 
is important to note, however, that ROS are only part of the story. The inflammatory 
response must also be considered.  Nonetheless ROS play a key role and to date, 
pharmacological treatment targeting ROS has thus far proven ineffective likely due to the 
46 
 
inability to deliver effective concentrations of the drug to sub-cellular targets at the critical 
stages of ROS generation during early reperfusion.  
Mitochondria are the primary source of post-ischemic ROS generation. ETC hyper-
activation due to changes (i.e., primarily loss) of post-translational modifications during 
ischemia  promotes hyperpolarization of the mitochondrial membrane potential at the 
early phase of reoxygenation after ischemia and thus an exponential increase in 
mitochondrial ROS production. Thus a treatment needs to be found that targets 
mitochondria to limit reperfusion injury.  
A series of studies looking at systemic hypothermia or mild hypothermia showed 
promise in reducing brain injury following cardiac arrest in the dog model. (Leonov, Sterz 
F Fau - Safar, Safar P Fau - Radovsky, and Radovsky 1990; Leonov, Sterz F Fau - Safar, 
Safar P Fau - Radovsky, Radovsky A Fau - Oku, et al. 1990; Sterz et al. 1991; Weinrauch 
et al. 1992; Kuboyama et al. 1993; Safar et al. 1996) In patients, therapeutic hypothermia 
was first shown to be effective in a seminal study in the late 1950’s which reduced 
mortality following global brain ischemia in patients who had suffered from cardiac 
arrest.(Benson Dw Fau - Williams et al. 1959) Furthermore, two large clinical trials in 
recent years have shown the therapeutic benefit of hypothermia following cardiac 
arrest.(Bernard et al. 2002; 'Mild therapeutic hypothermia to improve the neurologic 
outcome after cardiac arrest'  2002) Several groups have reported that in MCA occluded 
rats hypothermia applied for as late as 3 hours following reperfusion could significantly 
reduce infarct volume up to 50%-90%.(Huh et al. 2009; Maier et al. 2001) The Cooling 
for Acute Ischemic Brain Damage (COOL AID) clinical trial showed some promise using 
endovascular cooling in acute ischemic stroke but concluded that more studies were 
needed.(De Georgia et al. 2004) Moreover, animal models of ischemia/reperfusion injury 
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have shown that hypothermia could reduce ROS production as well as improve 
mitochondrial function in the heart and the brain.(Gong et al. 2012; Tissier et al. 2013) 
Therapeutic hypothermia decreases cerebral metabolic rate by 6-7% for every 1 degree 
decrease in body temperature, which in turn reduces oxygen demand of the brain. 
(Polderman 2009; Erecinska, Thoresen M Fau - Silver, and Silver 2003) Results from 
groups studying energy metabolism found that in rats that had undergone a normothermic 
ischemic insult for 30 minutes and a 2 hour recovery (reperfusion) at 30° C had no 
decrease in the activity of mitochondrial complexes II-III and IV. On the other hand, 
decreases of 15-30% were seen in animals that had recovered at physiological 
temperature of 37° C.(Canevari et al. 1999) Taylor et al. (2002) conducted studies in 
which they looked at 6-hour whole body cooling to 30° C after three hours of normothermic 
brain hypoxia-ischemia in 7 day old rat pups.(Taylor et al. 2002) When the pups were 
sacrificed at 14 days, the PCr/Cr ratios were identical to control animals which indicated 
neural protection. Thus, mild, short-term hypothermia seems to normalize cerebral 
metabolic rate and reduce mitochondrial damage while increasing the duration of 
hypothermia can reduce secondary changes to energetics, including both mitochondria 
but also the immune response and thus salvage brain tissue.(Erecinska, Thoresen M Fau 
- Silver, and Silver 2003) 
As discussed in Chapter 2, previous studies from our group and others have 
uncovered a novel property of the terminal enzyme in the mitochondrial ETC, cytochrome 
c oxidase (CcO). It was found that this enzyme has photoreceptive properties that allow 
CcO activity to be regulated by specific wavelengths of near infrared light (NIR).  Previous 
studies demonstrated that CcO activity can be stimulated by applying NIR wavelengths 
of 670 nm and 808 nm, thus increasing mitochondrial respiration. The CcO multi-protein 
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complex has several chromophores involved in enzyme catalysis. It is well-accepted that 
the primary cellular photoreceptor for NIR are the catalytic copper centers of CcO, with a 
broad absorbance spectra covering the NIR range of 700-1000nm.  
Based on our model, however, increasing CcO activity during reperfusion would 
be counterproductive since ETC complexes are already hyperactive due to changes in 
their post-translational modifications leading to exponential ROS production during early 
reperfusion. Our group has found that CcO activity can be reduced by applying inhibitory 
NIR wavelengths (750 nm and 950 nm and the combination). Reduction of CcO activity 
by inhibitory NIR leads to transient, reversible reductions in both mitochondrial respiration, 
and the mitochondrial membrane potential. This in turn would lead to a reduction in the 
amount of superoxide produced, thus salvaging neurons, a finding that our lab showed in 
cell culture following oxygen glucose deprivation. Moreover, in addition to cell culture 
models, we have shown profound neuroprotection of NIR in vivo in the rat model of global 
brain ischemia in which we saw up to 89% of CA1 hippocampal neurons salvaged due to 
NIR irradiation applied during reperfusion compared to 14% of surviving neurons in the 
controls. While these results have been promising, further questions remain regarding its 
applicability to a focal brain injury like acute ischemic stroke, which differs in the 
pathological evolution and severity from the global brain ischemia, the latter mimicking 
brain injury following cardiac arrest/resuscitation.  
It was therefore our goal in this study to test the preclinical efficacy of this therapy 
in focal brain ischemia (stroke) using the rat middle cerebral artery occlusion (MCAO) 
model.  We hypothesize that dual-wavelength NIR applied during reperfusion following 
stroke will provide profound neuroprotection as shown through significant reductions in 
infarct volume measured by multiple, clinically translatable MRI modalities. We also 
49 
 
hypothesized that NIR therapy would directly target salvageable penumbral tissue which 
would be measured by a significant perfusion/diffusion mismatch. Furthermore, we 
sought to uncover whether two treatment durations of NIR would influence infarct size at 
the acute, subacute and chronic time points. Building on our previous data, our first aim 
was to modulate mitochondrial activity for 120 minutes, initiated at reperfusion, to limit 
ROS bursts during early reperfusion. We next sought to extend treatment duration to 240 
minutes, building on the results from the hypothermia literature. 
Materials and Methods 
Chemicals, reagents, and diodes 
Chemicals and reagents were obtained from Sigma-Aldrich (St. Luis, Montana, 
USA) unless otherwise stated. Light emitting diodes (LEDs) were obtained from Roithner 
Lasertechnik (Vienna, Austria). For animal experiments LED array 60 chips were used 
(750 nm, LED750-66-60; 950 nm, LED950-66-60). Diodes were mounted on heat sinks 
(black aluminum, 47x20 for LED array 60 chips) together with a small fan (EC3010M05X; 
Evercool, New Taipei City, Taiwan) operated in reverse mode. Diodes were calibrated 
with an optical power and energy meter (842-PE; Newport, Irvine, California, USA) and 
operated with an energy density of 200 mW/cm2. 
Experimental Design 
Animal use protocols were approved by the Wayne State University Institutional 
Animal Care and Use Committee and all experiments were performed in accordance with 
the IACUC protocol and relevant regulations. Animals were given free access to food and 
water prior to surgery and all surgical procedures were held around the same time of day 
to prevent confounding effects of daily humoral cycles. Animals underwent 90 minutes of 
transient right middle cerebral artery occlusion as described below. One hour into 
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ischemia, animals were placed in the MRI and arterial spin labeling (ASL) and diffusion 
weighted imaging (DWI) sequences were obtained. Animals were allowed to recover from 
the anesthesia until a few minutes before the 90-minute ischemic period was to end at 
which time they were re-anesthetized and the incision opened. After 90 minutes, the 
filament was withdrawn and treatment immediately initiated for 120 minutes. Following 
the treatment duration, animals were taken off the isoflurane and transported again to the 
MRI where ASL and DWI scans were obtained. Following these scans, the animals were 
given a subcutaneous injection of buprenorphine (0.015mg/kg) in 10 cc of saline and 
allowed to recover in a temperature/humidity controlled environment. Twenty-four hours 
following reperfusion the following MRI sequences were obtained: ASL, DWI, T2 weighted 
imaging (the transverse, spin-spin relaxation time).  After these scans animals were given 
15 cc of subcutaneous dextrose injections (5% in 0.95% NaCl) twice a day as we found 
a reduction in water intake because of stroke. On days 7 and 14  the animals were again 
imaged and the above-mentioned scans acquired. On day 14, following the MRI scans, 
animals were sacrificed by transcardial perfusion with phosphate buffered saline followed 
by 4% paraformaldehyde. Brains were removed and post-fixed in PFA for 24 hours and 
then cryoprotected in a sucrose gradient (20%, 30%) until they were sectioned on a 
cryostat at 50 micrometer coronal sections and stained with H&E for histological analysis.  
Middle Cerebral Artery Occlusion/Reperfusion 
Focal brain ischemia was induced in two randomly assigned groups of male 
spontaneously hypertensive rats (223-336 g purchased from Envigo) through the middle 
cerebral artery occlusion method as previously described (Uluç, 2011-Longa, 1989). Briefly, 
animals were anesthetized with isoflurane (5% induction, 2% maintenance in a mix of 
70% nitrous oxide, 30% oxygen). The animals’ temperature was closely monitored by a 
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homeothermic blanket (Harvard Apparatus) and kept at 37º C. A neck incision was made 
at the midline and underlying connective tissue was removed through blunt dissection 
until the common, external, and internal carotid arteries were visualized. The superior 
thyroid and occipital arteries, as well as the external carotid were permanently ligated with 
a 6-0 silk suture. Next, a commercially available silicon coated tip monofilament suture 
(Doccol corporation) was inserted through an incision made in the external carotid and 
advanced into the internal carotid artery until it sat at and occluded the origin of the MCA 
(18-20 mm from the carotid bifurcation). The suture was secured in place and the incision 
quickly sutured and the animal was given subcutaneous injections of lidocaine (20mg/mL 
diluted 1:4) around the incision, taken off the isoflurane and allowed to recover in a 
temperature- and humidity-controlled chamber for 90 minutes. We found in a pilot study 
that 90 minutes of ischemia was the optimal time for causing reproducible infarcts without 
increasing animal mortality. Following 90 minutes of ischemia animals were re-
anesthetized with the above isoflurane protocol, the incision reopened, the filament 
withdrawn and NIR treatment immediately initiated (see below).  
Administration of NIR Treatment 
NIR was administered directly to the intact scalp as previously described 
(Sanderson, 2018). Briefly, LEDs were placed 1.5 cm from the scalp which had been 
shaved of fur to prevent light loss due to absorbance and reflection. LED intensity was 
200 mW/cm2 which converts to 2000 joules/second/meter squared as a dose of energy.   
Animals were treated with combined CcO-inhibitory wavelengths of 750nm and 950nm 
as it was shown to be most effective by our previous work. Irradiation began immediately 
when the filament was withdrawn and continued for 120 minutes (first group) and 240 
minutes (second group). During treatment the animals were kept anesthetized on 
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isoflurane (1.5%) and on a homeothermic blanket (Harvard Apparatus) which kept core 
temperature at 37º C. Control animals underwent the same procedure (duration, 
anesthesia) but were not irradiated with NIR. Moreover, Sanderson et al. demonstrated 
in vivo that during irradiation with the combined wavelengths, brain temperature remained 
constant around 36º C.(Sanderson et al. 2018)  
Imaging Procedures and Analysis 
All MRI protocols were performed on a 7.0-Tesla, 20-cm bore superconducting 
magnet (ClinScan; Bruker, Karlsruhe, Germany) that was interfaced with a Siemens 
console. Prior to imaging, animals were anesthetized with isoflurane (4% induction in 
room air, 1.75% maintenance).  Animals were first subjected to a series of localization 
scans. Next, pulsed arterial spin labeling was acquired according to the following 
sequence parameters: Relaxation time (TR) of 3500 ms; TE of 16 ms; FoV read 35.0 mm; 
FoV phase 81.3%; distance factor 25%; slice thickness 2.0 mm; 4 slices. Next diffusion 
weighted imaging (DWI) sequence was conducted according to the following parameters: 
TR 10000ms; TE 50 ms; FoV read 32.0mm; FoV phase 100.0%; distance factor 0%;  slice 
thickness 0.5 mm; 32 slices. Following this a T2 weighted imaging scan was acquired 
according to the following parameters: TR 3530 ms; TE 38 ms; FoV read 32 mm; FoV 
phase 100.0%; distance factor 0%; slice thickness 1.0 mm; 24 slices. Relative cerebral 
blood flow in the MCA territory during ischemia and reperfusion was calculated as 
previously described and discussed in Chapter 3.  Briefly, voxel intensity in ipsilateral and 
contralateral hemispheres was averaged across three coronal slices using ImageJ, giving 
the average relative cerebral blood flow (relCBF) voxel intensity value. Then, using the 
kinetic model equations, CBF was calculated for both hemispheres giving cerebral blood 
flow rates in mL/100g/min. In order to calculate at-risk volume, interspace gap had to be 
53 
 
considered along with slice thickness when multiplying the sum of hypoperfused areas. 
When this was done, it was seen that the volume generated was significantly smaller than 
the infarct volume that was calculated at 24 hours which is anatomically impossible. The 
slice thickness in ASL sequences is 2 mm apart and the software reports an interspace 
gap of 25% in order to account for slice cross talk – or interference between slices during 
image reconstruction. When incorporating the interspace gap with the slice thickness, 
volumes were still too small and thus a correction factor was derived. Whole brains were 
traced from ASL sequences of each animal in the two-hour treatment group using the 
relCBF images at 2 hours following reperfusion and areas were summed. Then, 
AnalyzePro software generated whole brain volumes from each brain (described below) 
using the 2-hour reperfusion DWI sequence. The DWI whole brain volume was divided 
by the ASL sum of areas to generate a correction factor for each animal. When the mean 
of the correction factors in the group was taken it gave 3.2. Thus, the sum of the ASL at-
risk areas were multiplied by 3.2 to give at risk volume in mm3.  
Infarct volumes were computed using the semi-automated segmentation tool in 
Analyze 11.0 (Biomedical Imaging Resource, Mayo Clinic, Rochester, MN). Seed points 
were set in the hyperintense MCA territory and thresholds based on voxel intensity were 
set until the entire region was outlined. The software then automatically calculated the 
area within that voxel intensity on each slice of the MRI sequence and multiplied the sum 
of the areas by slice thickness to generate a volume which was reported as mm3.  
Statistical Analysis 
Relative cerebral blood flow between groups were compared using an unpaired, 
two-tailed t-test with a critical level set to 0.05. Infarct volumes were computed using a 
two-way ANOVA with the Neuman-Keuls test for post-hoc analysis. Slopes and intercepts 
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of the PWI/DWI mismatch lines were compared by linear regression with significance set 
at 0.05. Slopes and intercepts of perfusion/diffusion mismatch lines were compared using 
Analysis of Co-variance (ANCOVA) and the Prism graph pad software.  
Apomorphine Induced Rotation Test for Functional Recovery  
Fourteen days following reperfusion animals that received four hours of NIR 
treatment were administered a rotameter test for functional recovery following stroke. The 
rotameter measures the number of clockwise turns an animal completes. Because of 
unilateral MCA occlusion damage to subcortical structures in the striatum, rats with a 
more severe injury will show increased clockwise turns in response to the dopamine 
agonist apomorphine. Animals were administered a subcutaneous injection of 
apmorphine (1 mg/mL, 0.1 mL per 100 g body weight) and the compound was allowed to 
reach peak activity which, according to Modo et al. was 30 minutes following the 
injection.(Modo et al. 2000) Then, the animals’ rotations were recorded for 30 minutes 
and the number of clockwise rotations summed. We opted to sum the total number of 
clockwise rotations rather than do a ration of clockwise over counterclockwise because 
animals were not making counterclockwise turns.  
Results 
Measurements of Relative Cerebral Blood Flow During Ischemia and Reperfusion 
Analysis of cerebral blood flow during ischemia and reperfusion were assessed 
using arterial spin labeling perfusion weighted MRI (ASL-PWI) in the ipsilateral and 
contralateral hemispheres (Figure 1) (Liebeskind 2003, Fau et al 1977, Turrens, et al. 
1985, Mitchell and Moyle 1967, Kadenbach et al 2010). During ischemia, all animals 
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showed significant reductions in blood flow below established relCBF thresholds on the 
ipsilateral hemisphere without accompanying changes in flow on the contralateral 
hemisphere.  Following treatment or no treatment, we repeated ASL scans and confirmed 
that the ipsilateral hemisphere was adequately perfused to levels comparable with the 
contralateral. Interestingly, there was no significant difference in relCBF between within 
the ipsilateral hemispheres of control and treated animals either during ischemia or 
reperfusion. Figure 4 shows the relative cerebral blood flow rates for animals treated for 
4 hours. The untreated ischemic hemisphere had blood flow reduced to 10.94 mL/100 
g/min on average while the contralateral hemisphere maintained physiological flow rates 
of 50.78 mL/100 g/min.   
Figure 1. Relative blood flow during ischemia and following reperfusion. A. Experimental protocol: 
untreated control animals and NIR treated experimental animals both underwent MCAO with 90 minutes
of ischemia. 60 minutes into ischemia a pulsed ASL sequence was obtained. Following 90 minutes of
ischemia the filament was removed and treatment initiated for 120 minutes after which time ASL images
were re-acquired. B. Representative ASL scans from both groups both during ischemia and following
reperfusion. C. Averaged regional cerebral blood flow in the ipsilateral MCA territory and contralateral 
hemisphere both during ischemia and following reperfusion. 
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Infarct Volume in the Acute Phase of Stroke 
We next looked at the effect of NIR on infarct volume in the acute phase of stroke, 
which we defined as 2 hours and 24 hours following MCAO/reperfusion (Figure 2A). Since 
DWI has been shown to be the most effective imaging modality both in quantification of 
early cytotoxic edema early on during brain ischemia, as well as predictive of final infarct 
size, we calculated DWI hypertensities during the acute phase (b=1000). Figure 2B shows 
that infarct sizes, which were acquired immediately post treatment (2 hours after 
reperfusion), did not significantly differ between NIR treated and control groups, although 
the infarct volumes of the treated 
animals were more spread than 
the untreated controls (control: 
256.138 mm3 ± 13.16; NIR 
treated: 210.377 mm3 ± 29.09, 
p>0.05). At 24 hours following 
Figure 2. MRI analysis of cerebral
injury in the acute reperfusion phase.
A. Experimental design: with 2 hours of
treatment. DWI images were obtained
and (B) no significant difference in 
infarct volume was seen between NIR
treated and control animals. B
(continued): compared with untreated
controls, NIR treated MCAO rats
showed significant reduction of infarct
volume at 24 hours as measured by
DWI. C. Perfusion diffusion mismatch.
Non-linear relationship was seen
between at risk area analyzed by ASL at
1 hour ischemia (x-axis) and infarcted
area (y-axis) 2 hours following
reperfusion. At 24 hours linearity is seen
where there is a positive correlation
between the at-risk and ischemic areas. 
Statistical analysis was conducted by an
unpaired, two-tailed t-test with
significance set at p<0.05. 
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reperfusion, animals were re-imaged and based on infarct volumes that were calculated 
again using DWI (b=1000), NIR-treated animals showed a significant reduction of 20.5% 
in infarct size when compared to untreated controls: 398.86 mm3 ± 20.54 vs. 317.03 mm3 
± 23.96, p<0.05 (Figure 2B). The two-way ANOVA also indicated that infarct volumes 
were significantly different from 2 to 24 hours between both groups thus suggesting that 
the infarcts evolved over time. We next asked whether there was a mismatch between 
diffusion and perfusion weighted imaging. We theorized that a mismatch between at-risk 
volume calculated during ischemia and ischemic hyperintensities would mean that viable 
tissue in the penumbra was being salvaged by the therapy.  Figure 2C shows the 
relationship between at risk volume, which was calculated using ASL images 1 hour into 
ischemia, and infarcted tissue taken from DWI images at both 2 and 24 hours post 
reperfusion. At 2 hours following reperfusion no relationship is seen between at-risk and 
ischemic tissue. At 24 hours, however, a positive linear relationship is seen in both treated 
and untreated animals suggesting that infarct size could be correlated to the size of at-
risk tissue. Despite the linearity of the relationship, the means of infarct volume remained 
different even though at risk tissue remains the same between both groups. 
Figure 5A shows infarct volumes (in mm3) between NIR treated and untreated 
animals, treated with NIR for 4 hours following reperfusion. A significant difference was 
seen between two groups in the early reperfusion phase (control group: 228.4 mm3, SD 
39.79; NIR treated group: 138.4 mm3, SD 82.623; p=0.0229). Next, DWI hyperintense 
lesion volumes were calculated from scans taken 24 hours following reperfusion. A highly 
significant 24% reduction in infarct volume was observed between control (351.3 mm3, 
SD 51.25) and NIR-treated (266.3 mm3, SD 50.62; p=0.0088) animals. Moreover, a 
significant difference was seen in infarct volumes from 4 to 24 hours in both groups as 
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calculated by two-way ANOVA indicating that the infarcts continued to evolve from 4 to 
24 hours.  
Figure 6A shows the perfusion/diffusion mismatch with at-risk area obtained from 
pulsed ASL perfusion weighted imaging 60 minutes into ischemia, and area of infarction 
obtained from DWI 4 hours following reperfusion. When analysis of covariance was 
performed, the slopes of the lines were not significantly different (p=0.41) but the 
intercepts were significantly different (p=0.031). 6B shows at-risk area plotted against 
area with the area of infarction obtained 24 hours post reperfusion. As at the 4 hour time 
point, ANCOVA results indicated that the slopes of the two lines are not significantly 
different (p=0.23) while the intercepts are highly significant (p=0.0061). What this means 
is that while the distribution of at-risk volumes remains the same between both groups, 
the treated animals displayed smaller MRI-measured infarcts. This indicates to us that 
tissue that was at risk to become infarcted following reperfusion was salvaged by the 
therapeutic intervention.  
Infarct Volume in the Chronic Phase of Stroke 
Early therapeutic efficacy in the context of stroke has shown promise acutely but 
diminished in chronic stroke.(Schellinger et al. 2012; Lees et al. 2012; Mergenthaler and 
Meisel 2012; Gladstone, Black Se Fau - Hakim, and Hakim 2002; Lapchak, Zhang Jh Fau 
- Noble-Haeusslein, and Noble-Haeusslein 2013) Thus, it was necessary to assess 
whether the therapeutic benefits of NIR in reducing infarct size were maintained during 
the chronic phase of stroke. To accomplish this, T2 weighted MRI images were acquired 
at 7 and 14 days following MCAO/reperfusion (Figure 3A). Seven days following MCAO 
NIR treated animals maintained a significant 25.4% reduction in infarct size when 
compared to untreated control animals: 363.3 mm3 vs 270.7 mm3, p=0.015 (Figure 3B). 
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Fourteen days after MCAO 
and prior to sacrificing the 
animals, T2WI images were 
acquired and a significant 
reduction of infarct size of 
24.9% between control and 
treated animals was observed: 
316.9 mm3 vs. 240.8 mm3, 
p=0.015 (Figure 3B). 
Furthermore, there was no 
significant difference in infarct 
volumes from 7 to 14 days. 
These data demonstrate 
significant reduction in infarct 
volumes, as measured by 
multiple MRI modalities, 
following NIR treatment both 
acutely and chronically 
following MCAO/reperfusion; 
however, as measured by the 
ANOVA, the infarcts remained 
fully evolved by 7 days even though the treatment effect remained to 14 days.  We 
analyzed the relationship between at-risk tissue (PWI) and infarcted tissue (T2WI) during 
the chronic phase of stroke and found that despite an even spread of the data along the 
Figure 3. Cerebral infarct in chronic phase of post-stroke 
reperfusion injury. A. experimental design: 7 and 14 days 
following reperfusion T2WI images were acquired. B. 7 days. 
Compared with untreated controls, NIR treated MCAO rats 
showed a significant reduction in infarct volume. Significant 
reduction in infarct volume persisted to 14 days post stroke. 
Statistical analysis was conducted by an unpaired, two-tailed t-test 
with significance set at p<0.05. C. PWI/DWI mismatch. 
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x-axis (indicating a range of at-risk volumes during ischemia), there was reduced infarcted 
volume in the NIR treated group (Figure 3C) at both 7 and 14 days post reperfusion.   
We next assessed whether a 4 hour treatment duration would improve the 
neuroprotective effect by targeting the acute and chronic phases of reperfusion injury. 
Using T2 weighted imaging, control and NIR treated animals were scanned 7 days 
following reperfusion (Figure 3A). T2 hyperintensities yielded a highly significant 48% 
difference in volume between control (449.3 mm3, SD 16.4) and NIR-treated (234.8 mm3, 
SD 111.2) animals (p=0.0056). We next asked whether this difference would persist to 
14 days following reperfusion. As shown in Figure 3B, using T2 weighted imaging, infarct 
volumes showed a significant 48% reduction in stroke size between control and NIR 
treated animals (control: 339.9 mm^3, SD 73.92; NIR treated: 178.4 mm^3, SD 113.3; 
p=0.036) with no significant difference in infarct evolution from 7 to 14 days.  
We next examined the PWI/DWI mismatch during the chronic phase of 4-hour 
treated animals.  Figure 6C shows at risk area plotted with infarction area at 7 days. 
Slopes remain non-significant (p=0.34) while intercepts show significant difference 
(p=0.018).  Figure 6D shows at-risk area plotted against area of infarction at 14 days.  
Two-Hour Treatment Histology 
At 14 days animals were sacrificed and transcardially perfused as described 
above. Due to the variability in tissue integrity following the staining protocol, we 
measured the volume of non-infarcted tissue on the ipsilateral hemisphere rather than the 
infarct volume. Because infarcted tissue is fragile 14 days after injury, accurate 
assessment of the tissue was not precise.  Figure 4 shows the volume of non-ischemic 
tissue reported in mm3. NIR-treated animals had significantly more non-infarcted tissue 
on the ipsilateral hemisphere than untreated controls (237.4 mm3, SD 29.95 vs. 200 mm3, 
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SD 17.44; p=0.042). 
Apomorphine-Induced Rotation Test for Functional Recovery  
We next looked at whether NIR treated animals showed evidence of functional 
recovery in addition to having smaller infarct volumes both acutely and chronically (Figure 
5). No significant difference was seen between control and treated animals (control: 119, 
SD 49.74; NIR treated: 83.14, SD 56.05; p=0.28).  
 
Figure 4. Histological analysis 14 days post-stroke. Volume of non-ischemic ipsilateral hemisphere 
tissue calculated from H&E stained tissue slices. NIR-treated animals had significantly more non-ischemic 
tissue in the ipsilateral hemisphere than untreated controls. 
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 Figure 5. Relative cerebral blood flow during ischemia and following a 4 hour NIR treatment. 
Averaged regional relative cerebral blood flow in the ipsilateral and contralateral MCA territories during 
ischemia and following 4 hours of reperfusion. The untreated ischemic hemispheres showed average flow 
rates of 10.94 mL/100 g/min while the contralateral hemisphere had flow rates of 50.78 mL/100 g/min. 
Those animals that would receive NIR treatment had ipsilateral MCA territory flow rates 12.125 
mL/100g/min during ischemia while the contralateral hemisphere had 53.8 mL/100 g/min. Following 
reperfusion, ipsilateral hemispheres of untreated animals had an average flow rate of 85.92 mL/100 g/min 
while the contralateral side had 62.04 mL/100 g/min. The ipsilateral hemispheres of the NIR treated animals 
had flow rates of 86.03 mL/100 g/min following 4 hours of reperfusion while the contralateral hemisphere 
had 63.8 mL/100 g/min.  
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Figure 6. A. Infarct volumes in the acute 
phase of stroke in MCAO rats treated for 
4 hours. Diffusion weighted imaging data 
was acquired 4 hours following 
reperfusion. Results are reported as infarct 
volume in mm3 and were based on DWI 
hyperintensities. A significant difference 
was seen between control animals (228.4 
mm3, SD 39.79) and NIR-treated animals 
(138.4, SD 82.23), p=0.023. B. DWI-based 
infarct volumes 24-hours following 
reperfusion. A significant difference 
between control animals (351.3 mm3, SD 
51.25) and NIR-treated animals (266.3 
mm3, SD 50.62) was observed in the acute 
phase of stroke, p=0.0088. 
Perfusion/Diffusion mismatch. C, at-risk 
area during ischemia vs area of infarction 
at 4 hours following reperfusion plotted 
against area of infarction. The slopes of the 
two lines are non-significantly different 
(p=0.41); the intercepts of the lines are 
significantly different (p=0.031). D. At risk 
area vs infarction 24 hours following 
reperfusion. Slopes of the lines are not 
significantly different (p=0.23); intercepts 
are significantly different (p=0.0061) 
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Figure 7. T2 Weighted imaging 
infarct volumes during the chronic 
phase of stroke in MCAO rats. A. 
Seven days following reperfusion, NIR 
treated animals showed a significant 
difference in infarct volume when 
compared with untreated controls 
(control: 449.3 mm3, SD 16.4; NIR 
treated: 234.8 mm3, SD 111.2). B. 
Fourteen days following reperfusion, 
the significant difference seen at 7 
days persisted (control: 339.9 mm3, SD 
73.92; NIR treated: 178.4 mm3, SD 
113.3). C. At risk area vs area of 
infarction 7 days post reperfusion. 
Slope of the lines is not significantly 
different (p=0.34); intercepts show 
significant difference (p=0.018). D. At 
risk vs infarction 14 days following 
reperfusion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Apomorphine induced rotation behavioral test 
data. NIR treated animals trended towards fewer clockwise 
rotations when given apomorphine than untreated controls 
(control: 199, SD 49.74; NIR treated: 84.17, SD 61.33; p= 0.28). 
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CHAPTER 5 - DISCUSSION: APPLICATIONS AND FUTURE DIRECTIONS  
Discussion 
Ischemic stroke accounts for about 9% of deaths globally and is the second leading 
cause of death following heart disease. Those who survive this debilitating disease often 
face a lifetime of neurological deficits and hence a drastic reduction in quality of life. Unlike 
other diseases, neurological pathologies such as stroke can affect all aspects of a 
person’s life – cognitive, emotional and functional – and in many ways hinder his or her 
ability to live fully. Stroke treatment has come a long way in the last several decades 
though there is still much work to be done. What once was palliative and supportive care 
has burgeoned into nuanced and individualized paradigms tailored to each patient’s 
disease and prognosis. 
The gold standard for stroke treatment is rapid restoration of blood flow in order to 
reverse neuronal injury and cell death, though this can perpetuate brain injury through the 
production of ROS during early reperfusion, though this is not the only detrimental effect 
of reperfusion. Oxidative stress is a common pathological mechanism in many disease 
states which arises from an imbalance between ROS production and ROS scavenging. 
Once produced, ROS damage cells either directly, or through diverse and complex cell 
signaling cascades damage DNA, proteins and lipids.(Zimmerman 1995) In chapter 1 of 
this work we laid out a theoretical framework in which we argued that ROS production is 
exponentially related to mitochondrial membrane potential. Membrane potential, in turn, 
is subject to fluctuations in both substrate availability, and, in higher organisms, post-
translational modifications such as changes in the phosphorylation states of ETC 
enzymes. We argued that enzymatic dephosphorylation during ischemia led to priming 
for hyperactivation which, upon reperfusion, resulted in large increases in membrane 
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potential and bursts of ROS. It has thus become a critical objective of both stroke 
clinicians and stroke researchers to target reperfusion injury at its source and therefore 
to save neurons.  Pharmacologic agents targeting ROS have been shown to be ineffective 
and thus an adjuvant therapy to tPA or thrombectomy is critically needed to target 
reperfusion injury.  
In this study we sought to show the effectiveness of targeting ROS at their source: 
directly in the mitochondrial electron transport chain during the early period of blood flow 
restoration using infrared light therapy. Building on our previous work, we reasoned that 
this therapy is noninvasive, can be applied immediately at the onset of reperfusion and 
has shown to have sufficient penetrating depth to target brain tissue during reperfusion. 
We hypothesized that irradiation of the brain with combination dual wavelength NIR 
immediately upon reperfusion would reduce infarct size both acutely and chronically in 
stroke. Since this therapy targets the penumbra rather than the stroke core, we first 
needed to demonstrate that the MCA territory was sufficiently hypoperfused.  Our data 
indicate that cerebral blood flow which was averaged across three slices of perfusion 
weighted MRI is significantly reduced below ischemic thresholds in the ipsilateral 
hemisphere and returns to normal levels following reperfusion. Interestingly, infarct 
volumes were not different between treated and control animals immediately following 
treatment when animals were treated for 120 minutes but animals treated for 240 minutes 
showed significant reductions in infarct volume when compared to untreated controls. 
Importantly, these significant reductions in infarct volume persisted in both treatment-
duration groups when 24 hour DWI scans were taken. This suggests that NIR targets 
ROS-mediated pathways in the delayed neuronal death cascade that extends beyond the 
initial 120 minutes of reperfusion. While this suggests that neurons in the penumbra were 
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being salvaged by NIR therapy, we needed to confirm this by examining whether a 
significant mismatch existed between perfusion and diffusion weighted imaging. In 
chapter 3 of this dissertation we outlined a long-standing argument in neuroimaging that 
any difference between at-risk tissue and infarcted tissue as measured by perfusion and 
diffusion MRI modalities respectively could be considered a measure of hypoperfused 
areas that have not yet died and thus could be potentially salvaged. When we plotted at-
risk area against area of infarction in both the 120 minute and 240 minute treated groups, 
we saw non-significant slopes but statistically significant intercepts. A non-significant 
slope indicates that the rate of change between the two variables in both groups is the 
same – the lines are parallel. This suggests that the relationship between area at risk and 
area of infarction is linear, i.e., the area of infarction is proportional to the area at risk and 
this holds true for both treated and untreated groups. The elevation of the two lines, 
however, is significantly different indicating to us a mismatch between at-risk and 
infarction in treated animals. This finding allows us to conclude that in both the 120 minute 
and 240 minute NIR treated animals, neurons in the penumbra are being salvaged by our 
approach which results in significantly smaller infarct volumes overall at both 4 hours (in 
the 240 minute treated group) and 24 hours (in both groups).  
We next asked whether the benefit of NIR could be extended into the chronic 
phase of stroke.  Our data show that infarct volumes as measured by T2WI remained 
significantly smaller at 7 and 14 days post stroke in both 120 and 240 minute NIR treated 
animals. Moreover, PWI/DWI mismatches had intercepts that remained significantly 
smaller in both groups when compared to untreated controls. The animals treated for 240 
minutes had significant reductions in infarct volumes of about 50% at 7 and 14 days 
indicating to us that extending treatment duration significantly improves neurological 
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outcome as measured by clinically translatable imaging modalities.  Additional targeting 
of late-stage ROS production caused by excitotoxicity, inhibition of inflammatory cell 
conversion through ROS signaling in the immune cell as well as longer than predicted 
window of mitochondrial stress and other, unknown mechanisms can all potentially 
explain how the longer treatment duration had such profound reductions in infarct volume 
during the chronic phase of stroke.  
Finally, in the animals treated for 240 minutes we employed an apomorphine-
induced rotational test to see whether changes in infarct volume correlated to observable 
functional improvements in neurological function. Apomorphine is a non-selective 
dopamine agonist which exerts its action on D2-like and D1-like receptors. Unilateral 
striatal lesions lead to increased rotation in one direction when striatal dopaminergic 
neurons are agonized. Our data indicate that while on average 4-hour NIR treated 
animals had fewer rotations than untreated controls, these results were not statistically 
different. This data is promising and likely due to the large amount of variability seen in 
behavioral tests and the need for large sample sizes that are not feasible in such a 
study.(Rewell et al. 2017)   
Conclusions 
In conclusion, this is the first study of its kind demonstrating in the rat MCAO model 
that immediate, reversible, non-invasive inhibition of photoreceptive mitochondrial CcO 
by dual-wavelength NIR in vivo during reperfusion following focal stroke can have 
profound and sustained reductions in tissue death. Furthermore, these reductions in 
infarct volume were measured by clinically relevant MRI modalities, which allowed 
assessment of stroke evolution over time to be monitored in vivo and in real time as is 
done in the clinic. Thus, based on our previous work demonstrating that NIR treatment 
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limits mitochondrial ROS production when applied during reperfusion after global brain 
ischemia, we here demonstrate that such treatment reduces the progression of 
reperfusion injury following focal brain ischemia and thereby minimized brain damage 
caused by stroke. Furthermore, this work has shown that NIR can target more than the 
initial burst of ROS following reperfusion. Extending treatment duration to 240 minutes 
had profound effects on infarct volume that were sustained during the chronic phase of 
the stroke. It is likely that this is due to NIR affecting the immune response. As a result, 
this project has shifted the paradigm on the role that NIR can play at longer stages of the 
reperfusion injury process. Future studies ought to examine the effect of NIR on immune 
responses, and other potential long-duration targets of NIR in other brain 
ischemia/reperfusion pathologies 
 
 
 
  
70 
 
APPENDIX  
IACUC Protocol Approval Letter 
 
 
 
 
  
71 
 
REFERENCES 
1. Acin-Perez, R. et al. 2003. 'An intragenic suppressor in the cytochrome c oxidase 
I gene of mouse mitochondrial DNA.', Human molecular genetics, 12: 329-39. 
2. Adam-Vizi, V., and C. Chinopoulos. 2006. 'Bioenergetics and the formation of 
mitochondrial reactive oxygen species', Trends Pharmacol Sci, 27: 639-45. 
3. Al-Macki, N., et al. 2009. 'The spectrum of abnormal neurologic outcomes 
subsequent to term intrapartum asphyxia', Pediatr Neurol, 41: 399-405. 
4. Allisy-Roberts, Penelope, and Jerry Williams. 2008. 'Chapter 10 - Magnetic 
resonance imaging.' in Penelope Allisy-Roberts and Jerry Williams (eds.), Farr's 
Physics for Medical Imaging (Second Edition) (W.B. Saunders). 
5. Alsop, D. C., and J. A. Detre. 1995. 'Reduced transit-time sensitivity in noninvasive 
magnetic resonance imaging of human cerebral blood flow', J Cereb Blood Flow 
Metab , 16: 1236-49. 
6. Alsop DC and Detre JA. 1998. 'Multisection cerebral blood flow MR imaging with 
continuous arterial spin labeling', Radiology, 208: 410-6. 
7. Arnold, S., and B. Kadenbach. 1999. 'The intramitochondrial ATP/ADP-ratio 
controls cytochrome c oxidase activity allosterically', FEBS Letters, 443: 105-8. 
8. Astrup J Fau - Symon, L., N. M. Symon L Fau - Branston, N. A. Branston Nm Fau 
- Lassen, and N. A. Lassen. 1977. 'Cortical evoked potential and extracellular K+ 
and H+ at critical levels of brain ischemia', Stroke, 8: 51-7. 
9. Astrup, J., B. K. Siesjö, and L. Symon. 1981. 'Thresholds in cerebral ischemia - 
the ischemic penumbra', Stroke, 12: 723. 
10. Attwell, D., and S. B. Laughlin. 2001. 'An energy budget for signaling in the grey 
matter of the brain', J Cereb Blood Flow Metab, 21: 1133-45. 
72 
 
11. Back, T., M. Hoehn-Berlage, K. Kohno, and K. A. Hossmann. 1994. 'Diffusion 
nuclear magnetic resonance imaging in experimental stroke. Correlation with 
cerebral metabolites', Stroke, 25: 494. 
12. Badaut, Jérôme, Lorenz Hirt, Cristina Granziera, Julien Bogousslavsky, Pierre J. 
Magistretti, and Luca Regli. 2001. 'Astrocyte-Specific Expression of Aquaporin-9 
in Mouse Brain is Increased after Transient Focal Cerebral Ischemia', Journal of 
Cerebral Blood Flow & Metabolism, 21: 477-82. 
13. Badaut, Jérôme, François Lasbennes, Pierre J. Magistretti, and Luca Regli. 2002. 
'Aquaporins in Brain: Distribution, Physiology, and Pathophysiology', Journal of 
Cerebral Blood Flow & Metabolism, 22: 367-78. 
14. Bae, C.S., et al. 2004. 'Effect of Ga-as laser on the regeneration of injured sciatic 
nerves in the rat', In Vivo, 18: 489-95. 
15. Baird, A. E., and S. Warach. 1988. 'Magnetic resonance imaging of acute stroke', 
J Cereb Blood Flow Metab, 18: 583-609. 
16. Barber, P. A., D. G. Darby, P. M. Desmond, Q. Yang, R. P. Gerraty, D. Jolley, G. 
A. Donnan, B. M. Tress, and S. M. Davis. 1998. 'Prediction of stroke outcome with 
echoplanar perfusion- and diffusion-weighted MRI', Neurology, 51: 418. 
17. Barbier, E. L., M. Lamalle L Fau - Decorps, and M. Decorps. 2001. 'Methodology 
of brain perfusion imaging', J Magn Reson Imaging, 13: 496-520. 
18. Barja, G. 1999. 'Mitochondrial oxygen radical generation and leak: sites of 
production in states 4 and 3, organ specificity, and relation to aging and longevity', 
J Bioenerg Biomembr, 31: 347-66. 
19. Barja, G., and A. Herrero. 1998. 'Localization at complex I and mechanism of the 
higher free radical production of brain nonsynaptic mitochondria in the short-lived 
73 
 
rat than in the longevous pigeon', J Bioenerg Biomembr, 30: 235-43. 
20. Barron, J. T., J. E. Gu L Fau - Parrillo, and J. E. Parrillo. 1998. 'Malate-aspartate 
shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth 
muscle', J Mol Cell Cardiol, 30: 1571-9. 
21. Barros, L. F., Carla X. Castro J Fau - Bittner, and C. X. Bittner. 2002. 'Ion 
movements in cell death: from protection to execution', Biol Res, 35: 209-14. 
22. Barros, L. F., J. Hermosilla T Fau - Castro, and J. Castro. 2001. 'Necrotic volume 
increase and the early physiology of necrosis', Comp Biochem Physiol A Mol Integr 
Physiol, 130: 401-9. 
23. Beaulieu, C. 2002. 'The basis of anisotropic water diffusion in the nervous system 
- a technical review', NMR Biomed, 15: 435-55. 
24. Benjamin, E. J., M. J. Blaha, S. E. Chiuve, M. Cushman, S. R. Das, R. Deo, S. D. 
de Ferranti, J. Floyd, M. Fornage, C. Gillespie, C. R. Isasi, M. C. Jimenez, L. C. 
Jordan, S. E. Judd, D. Lackland, J. H. Lichtman, L. Lisabeth, S. Liu, C. T. 
Longenecker, R. H. Mackey, K. Matsushita, D. Mozaffarian, M. E. Mussolino, K. 
Nasir, R. W. Neumar, L. Palaniappan, D. K. Pandey, R. R. Thiagarajan, M. J. 
Reeves, M. Ritchey, C. J. Rodriguez, G. A. Roth, W. D. Rosamond, C. Sasson, A. 
Towfighi, C. W. Tsao, M. B. Turner, S. S. Virani, J. H. Voeks, J. Z. Willey, J. T. 
Wilkins, J. H. Wu, H. M. Alger, S. S. Wong, P. Muntner, Committee American Heart 
Association Statistics, and Subcommittee Stroke Statistics. 2017. 'Heart Disease 
and Stroke Statistics-2017 Update: A Report From the American Heart 
Association', Circulation, 135: e146-e603. 
25. Benson Dw Fau - Williams, G. R., Jr., F. C. Williams Gr Jr Fau - Spencer, A. J. 
Spencer Fc Fau - Yates, and A. J. Yates. 1959. 'The use of hypothermia after 
74 
 
cardiac arrest', Anesth Analg, 38: 423-8. 
26. Bernard, S. A., Michael D. Gray Tw Fau - Buist, Bruce M. Buist Md Fau - Jones, 
William Jones Bm Fau - Silvester, Geoff Silvester W Fau - Gutteridge, Karen 
Gutteridge G Fau - Smith, and K. Smith. 2002. 'Treatment of comatose survivors 
of out-of-hospital cardiac arrest with induced hypothermia', N Engl J Med, 346: 
557-63. 
27. Bivard, A., Christopher R. Spratt N Fau - Levi, Mark W. Levi Cr Fau - Parsons, and 
M. W. Parsons. 2011. 'Acute stroke thrombolysis: time to dispense with the clock 
and move to tissue-based decision making?', Expert Rev Cardiovasc Ther, 9: 451-
61. 
28. Bourdillon Pd Fau - Poole-Wilson, P. A., and P. A. Poole-Wilson. 1981. 'Effects of 
ischaemia and reperfusion on calcium exchange and mechanical function in 
isolated rabbit myocardium', Cardiovasc Res, 15: 121-30. 
29. Brennan, J. P., Rodolfo A. Southworth R Fau - Medina, Sean M. Medina Ra Fau - 
Davidson, Michael R. Davidson Sm Fau - Duchen, Michael J. Duchen Mr Fau - 
Shattock, and M. J. Shattock. 2006. 'Mitochondrial uncoupling, with low 
concentration FCCP, induces ROS-dependent cardioprotection independent of 
KATP channel activation', Cardiovasc Res, 72: 313-21. 
30. Burdette, J. H., A. D. Durden Dd Fau - Elster, Y. F. Elster Ad Fau - Yen, and Y. F. 
Yen. 2001. 'High b-value diffusion-weighted MRI of normal brain', J Comput Assist 
Tomogr, 25: 515-9. 
31. Buxton, R. B., E. C. Frank Lr Fau - Wong, B. Wong Ec Fau - Siewert, S. Siewert B 
Fau - Warach, R. R. Warach S Fau - Edelman, and R. R. Edelman. 1998. 'A 
general kinetic model for quantitative perfusion imaging with arterial spin labeling', 
75 
 
Magn Reson Med, 40: 383-96. 
32. Cadenas E Fau - Boveris, A., C. I. Boveris A Fau - Ragan, A. O. Ragan Ci Fau - 
Stoppani, and A. O. Stoppani. 1977. 'Production of superoxide radicals and 
hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c 
reductase from beef-heart mitochondria', Archives of Biochemistry and Biophysics, 
180: 248-57. 
33. Canevari, L., E. A. Console A Fau - Tendi, J. B. Tendi Ea Fau - Clark, T. E. Clark 
Jb Fau - Bates, and T. E. Bates. 1999. 'Effect of postischaemic hypothermia on 
the mitochondrial damage induced by ischaemia and reperfusion in the gerbil', 
Brain Res, 817: 241-5. 
34. Cao, G., Xiao Xing J Fau - Xiao, Anthony K. F. Xiao X Fau - Liou, Yanqin Liou Ak 
Fau - Gao, Xiao-Ming Gao Y Fau - Yin, Robert S. B. Yin Xm Fau - Clark, Steven 
H. Clark Rs Fau - Graham, Jun Graham Sh Fau - Chen, and J. Chen. 2007. 'Critical 
role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic 
neuronal injury', J Neurosci, 27: 9278-93. 
35. Carden, D. L., and D. N. Granger. 2000. 'Pathophysiology of ischaemia-
reperfusion injury', J Pathol, 190: 255-66. 
36. Chance B Fau - Williams, G. R., and G. R. Williams. 1955. 'Respiratory enzymes 
in oxidative phosphorylation. I. Kinetics of oxygen utilization', J Biol Chem, 217: 
383-93. 
37. Chance, B. and Hollunger, G. 1961. 'The interaction of energy and electron transfer 
reactions in mitochondria. I. General properties and nature of the products of 
succinate-linked reduction of pyridine nucleotide', J. Biol. Chem., 236: 1534-43. 
38. Cheng, E. H., S. Wei Mc Fau - Weiler, R. A. Weiler S Fau - Flavell, T. W. Flavell 
76 
 
Ra Fau - Mak, T. Mak Tw Fau - Lindsten, S. J. Lindsten T Fau - Korsmeyer, and 
S. J. Korsmeyer. 2001. 'BCL-2, BCL-X(L) sequester BH3 domain-only molecules 
preventing BAX- and BAK-mediated mitochondrial apoptosis', Mol Cell, 8: 705-11. 
39. Chobot, S.E., Zhang, H., Moser, C.C, & Dutton, P.L. 2008. 'Breaking the Q cycle: 
finding new ways to study Qo through thermodynamic manipulations', Journal of 
bioenergetics and biomembranes, 40. 
40. Choi, K., Gyung W. Kim J Fau - Kim, Chulhee Kim Gw Fau - Choi, and C. Choi. 
2009. 'Oxidative stress-induced necrotic cell death via mitochondira-dependent 
burst of reactive oxygen species', Curr Neurovasc Res, 6: 213-22. 
41. Chouchani, E. T., V. R. Pell, E. Gaude, D. Aksentijevic, S. Y. Sundier, E. L. Robb, 
A. Logan, S. M. Nadtochiy, E. N. J. Ord, A. C. Smith, F. Eyassu, R. Shirley, C. H. 
Hu, A. J. Dare, A. M. James, S. Rogatti, R. C. Hartley, S. Eaton, A. S. H. Costa, P. 
S. Brookes, S. M. Davidson, M. R. Duchen, K. Saeb-Parsy, M. J. Shattock, A. J. 
Robinson, L. M. Work, C. Frezza, T. Krieg, and M. P. Murphy. 2014. 'Ischaemic 
accumulation of succinate controls reperfusion injury through mitochondrial ROS', 
Nature, 515: 431-35. 
42. Chung J‐W Fau - Chung, Jong‐Won, Su Hyun Park Sh Fau - Park, Nayoung Kim 
N Fau - Kim, Wook‐Joo Kim W‐J Fau - Kim, Jung Hyun Park Jh Fau - Park, 
Youngchai Ko Y Fau - Ko, Mi Hwa Yang Mh Fau - Yang, Myung Suk Jang Ms Fau 
- Jang, Moon‐Ku Han M‐K Fau - Han, Cheolkyu Jung C Fau - Jung, Jae Hyoung 
Kim Jh Fau - Kim, Chang Wan Oh Cw Fau - Oh, and Hee‐Joon Bae H‐J Fau - Bae. 
2014. 'Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Classification and 
Vascular Territory of Ischemic Stroke Lesions Diagnosed by Diffusion‐Weighted 
77 
 
Imaging', J Am Heart Assoc, 3. 
43. Coifman, R. R., S. Lafon, A. B. Lee, M. Maggioni, B. Nadler, F. Warner, and S. W. 
Zucker. 2005. 'Geometric diffusions as a tool for harmonic analysis and structure 
definition of data: Diffusion maps', Proceedings of the National Academy of 
Sciences of the United States of America, 102: 7426. 
44. Coifman, Ronald R., and Stéphane Lafon. 2006. 'Diffusion maps', Applied and 
Computational Harmonic Analysis, 21: 5-30. 
45. Colbourne, F., A. M. Li H Fau - Buchan, J. A. Buchan Am Fau - Clemens, and J. 
A. Clemens. 1999. 'Continuing postischemic neuronal death in CA1: influence of 
ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats', Stroke, 
30: 662-8. 
46. Colbourne, F., R. N. Sutherland Gr Fau - Auer, and R. N. Auer. 1999. 'Electron 
microscopic evidence against apoptosis as the mechanism of neuronal death in 
global ischemia', J Neurosci, 19: 4200-10. 
47. Crofts, A.R. 2004. 'The cytochrome bc1 complex: function in context of structure', 
Annual Reviews of Physiology, 66: 689-733. 
48. Crofts, A.R., Berry, E.A. 1998. 'Structure and function of the cytochrome bc1 
complex of mitochondria and photosynthetic bacteria', Current Opinion in 
Structural Biology, 8: 501-09. 
49. Dalmonte, M. E. et al. 2009. 'Control of respiration by cytochrome c oxidase in 
intact cells: role of the membrane potential. ', The Journal of biological chemistry, 
284: 32331-35. 
50. Darby, D. G., R. P. Barber Pa Fau - Gerraty, P. M. Gerraty Rp Fau - Desmond, Q. 
Desmond Pm Fau - Yang, M. Yang Q Fau - Parsons, T. Parsons M Fau - Li, B. M. 
78 
 
Li T Fau - Tress, S. M. Tress Bm Fau - Davis, and S. M. Davis. 1999. 
'Pathophysiological topography of acute ischemia by combined diffusion-weighted 
and perfusion MRI', Stroke, 30: 2043-52. 
51. De Georgia, M. A., A. Krieger Dw Fau - Abou-Chebl, T. G. Abou-Chebl A Fau - 
Devlin, M. Devlin Tg Fau - Jauss, S. M. Jauss M Fau - Davis, W. J. Davis Sm Fau 
- Koroshetz, G. Koroshetz Wj Fau - Rordorf, S. Rordorf G Fau - Warach, and S. 
Warach. 2004. 'Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility 
trial of endovascular cooling', Neurology, 63: 312-7. 
52. DeGracia, Donald J., Doaa Taha, Fika Tri Anggraini, and Zhifeng Huang. 2017. 
'Neuroprotection Is Technology, Not Science.' in Paul A. Lapchak and John H. 
Zhang (eds.), Neuroprotective Therapy for Stroke and Ischemic Disease (Springer 
International Publishing: Cham). 
53. DeLellis, S.L., D.H. Carnegie, and T.J. Burke. 2005. 'Improved sensitivity in 
patients with peripheral neuropathy: effects of monochromatic infrared photo 
energy', J Am Podiatr Med Assoc, 95: 143-7. 
54. Deshpande, J., T. Bergstedt K Fau - Linden, H. Linden T Fau - Kalimo, T. Kalimo 
H Fau - Wieloch, and T. Wieloch. 1992. 'Ultrastructural changes in the 
hippocampal CA1 region following transient cerebral ischemia: evidence against 
programmed cell death', Exp Brain Res, 88: 91-105. 
55. Detaboada, L. et al. 2006. 'Transcranial application of low-energy laser irradiation 
improves neurological deficits in rats following acute stroke', Lasers Surg Med, 38: 
70-3. 
56. Detre, J. A., D. S. Leigh Js Fau - Williams, A. P. Williams Ds Fau - Koretsky, and 
A. P. Koretsky. 1992. 'Perfusion imaging', Magn Reson Med, 23: 37-45. 
79 
 
57. Detre, J. A., D. A. Zhang W Fau - Roberts, A. C. Roberts Da Fau - Silva, D. S. 
Silva Ac Fau - Williams, D. J. Williams Ds Fau - Grandis, A. P. Grandis Dj Fau - 
Koretsky, J. S. Koretsky Ap Fau - Leigh, and J. S. Leigh. 1994. 'Tissue specific 
perfusion imaging using arterial spin labeling', NMR Biomed, 7: 75-82. 
58. Dirnagl U, MA Iadecola C Fau-Moskowitz, and MA Moskowitz. 1999. 'Pathobiology 
of ischaemic stroke: an integrated view', Trends Neurosci, 22: 391-7. 
59. Easlon, E., Craig Tsang F Fau - Skinner, Chen Skinner C Fau - Wang, Su-Ju Wang 
C Fau - Lin, and S. J. Lin. 2008. 'The malate-aspartate NADH shuttle components 
are novel metabolic longevity regulators required for calorie restriction-mediated 
life span extension in yeast', Genes Dev, 22: 931-44. 
60. Edelman, R. R., D. G. Siewert B Fau - Darby, V. Darby Dg Fau - Thangaraj, A. C. 
Thangaraj V Fau - Nobre, M. M. Nobre Ac Fau - Mesulam, S. Mesulam Mm Fau - 
Warach, and S. Warach. 1994. 'Qualitative mapping of cerebral blood flow and 
functional localization with echo-planar MR imaging and signal targeting with 
alternating radio frequency', Radiology, 192: 513-20. 
61. Eells, J.T. et al. 2003. 'Therapeutic photobiomodulation for methanol-induced 
retinal toxicity', Proceedings of the National Academy of Sciences, 100: 3439-44. 
62. Eells JT1, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP, Gould 
LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT.. 2004. 'Mitochondrial 
signal transduction in accelerated would and retinal healing by near-infrared light 
therapy', Mitochondrion, 4: 559-67. 
63. Einstein, A. 1905. 'INVESTIGATIONS ON THE THEORY OF THE BROWNIAN 
MOVEMENT', Ann. der Physik. 
64. Erecinska, M., Ian A. Thoresen M Fau - Silver, and I. A. Silver. 2003. 'Effects of 
80 
 
hypothermia on energy metabolism in Mammalian central nervous system', J 
Cereb Blood Flow Metab, 23: 513-30. 
65. Fabian, R. H., T. A. DeWitt Ds Fau - Kent, and T. A. Kent. 1995. 'In vivo detection 
of superoxide anion production by the brain using a cytochrome c electrode', J 
Cereb Blood Flow Metab, 15: 242-7. 
66. Fang, Ji-Kang, Subbuswamy K. Prabu, Naresh B. Sepuri, Haider Raza, Hindupur 
K. Anandatheerthavarada, Domenico Galati, Joseph Spear, and Narayan G. 
Avadhani. 2007. 'Site Specific Phosphorylation of Cytochrome c Oxidase Subunits 
I, IVi1 and Vb in Rabbit Hearts Subjected to Ischemia/Reperfusion', FEBS Letters, 
581: 1302-10. 
67. Feigin, V. L., B. Norrving, and G. A. Mensah. 2017. 'Global Burden of Stroke', Circ 
Res, 120: 439-48. 
68. Ferré, J. C., E. Bannier, H. Raoult, G. Mineur, B. Carsin-Nicol, and J. Y. Gauvrit. 
2013. 'Arterial spin labeling (ASL) perfusion: Techniques and clinical use', 
Diagnostic and Interventional Imaging, 94: 1211-23. 
69. Fiskum, G. 2000. 'Mitochondrial participation in ischemic and traumatic neural cell 
death', J Neurotrauma, 17: 843-55. 
70. Fiskum, G., M. F. Murphy An Fau - Beal, and M. F. Beal. 1999. 'Mitochondria in 
neurodegeneration: acute ischemia and chronic neurodegenerative diseases', J 
Cereb Blood Flow Metab, 19: 351-69. 
71. Friberg, H., A. P. Connern C Fau - Halestrap, T. Halestrap Ap Fau - Wieloch, and 
T. Wieloch. 1999. 'Differences in the activation of the mitochondrial permeability 
transition among brain regions in the rat correlate with selective vulnerability', J 
Neurochem, 72: 2488-97. 
81 
 
72. Fujimura, M., K. Morita-Fujimura Y Fau - Murakami, M. Murakami K Fau - Kawase, 
P. H. Kawase M Fau - Chan, and P. H. Chan. 1998. 'Cytosolic redistribution of 
cytochrome c after transient focal cerebral ischemia in rats', J Cereb Blood Flow 
Metab, 18: 1239-47. 
73. Gladstone, D. J., Antoine M. Black Se Fau - Hakim, and A. M. Hakim. 2002. 
'Toward wisdom from failure: lessons from neuroprotective stroke trials and new 
therapeutic directions', Stroke, 33: 2123-36. 
74. Golay, X., Tchoyoson C. C. Hendrikse J Fau - Lim, and T. C. Lim. 2004. 'Perfusion 
imaging using arterial spin labeling', Top Magn Reson Imaging, 15: 10-27. 
75. Gong, P., Rong Li Cs Fau - Hua, Hong Hua R Fau - Zhao, Zi-Ren Zhao H Fau - 
Tang, Xue Tang Zr Fau - Mei, Ming-Yue Mei X Fau - Zhang, Juan Zhang My Fau 
- Cui, and J. Cui. 2012. 'Mild hypothermia attenuates mitochondrial oxidative stress 
by protecting respiratory enzymes and upregulating MnSOD in a pig model of 
cardiac arrest', PLoS One, 7. 
76. Granger, D. N., and P. R. Kvietys. 2015. 'Reperfusion injury and reactive oxygen 
species: The evolution of a concept', Redox Biol, 6: 524-51. 
77. Green, D. R., and J. C. Reed. 1998. 'Mitochondria and apoptosis', Science, 28: 
1309-12. 
78. Griffiths DE, Wharton DC. 1961. 'Studies of the electron transport system. XXXV. 
Purification and properties of cytochrome oxidase', J Biol Chem, 236: 1850-56. 
79. Guo, D., Mourad Nguyen T Fau - Ogbi, Huda Ogbi M Fau - Tawfik, Guochun Tawfik 
H Fau - Ma, Qilin Ma G Fau - Yu, Robert W. Yu Q Fau - Caldwell, John A. Caldwell 
Rw Fau - Johnson, and J. A. Johnson. 2007. 'Protein kinase C-epsilon 
coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with 
82 
 
improved cytochrome-c oxidase activity and cardioprotection', Am J Physiol Heart 
Circ Physiol, 293. 
80. Hacke, W. 2015. 'Interventional thrombectomy for major stroke--a step in the right 
direction', N Engl J Med, 372: 76-7. 
81. Hazeki O, Tamura M. 1988. 'Quantitative analysis of hemoglobin oxygenation state 
of rat brain in situ by near-infrared spectrophotometry', J Appl Physiol, 64: 796-
802. 
82. Hetz, C., Agnes Vitte Pa Fau - Bombrun, Tatiana K. Bombrun A Fau - Rostovtseva, 
Sylvie Rostovtseva Tk Fau - Montessuit, Agnes Montessuit S Fau - Hiver, Matthias 
K. Hiver A Fau - Schwarz, Dennis J. Schwarz Mk Fau - Church, Stanley J. Church 
Dj Fau - Korsmeyer, Jean-Claude Korsmeyer Sj Fau - Martinou, Bruno Martinou 
Jc Fau - Antonsson, and B. Antonsson. 2005. 'Bax channel inhibitors prevent 
mitochondrion-mediated apoptosis and protect neurons in a model of global brain 
ischemia', J Biol Chem, 280: 42960-70. 
83. Hirsch, T., I. Susin Sa Fau - Marzo, P. Marzo I Fau - Marchetti, N. Marchetti P Fau 
- Zamzami, G. Zamzami N Fau - Kroemer, and G. Kroemer. 2005. 'Mitochondrial 
permeability transition in apoptosis and necrosis', Cell Death And Differentiation, 
12: 1478-80. 
84. Hirst, J., Ian M. Carroll J Fau - Fearnley, Richard J. Fearnley Im Fau - Shannon, 
John E. Shannon Rj Fau - Walker, and J. E. Walker. 2003. 'The nuclear encoded 
subunits of complex I from bovine heart mitochondria', Biochem Biophys Acta, 
1604: 135-50. 
85. Hirst, J., Kenneth R. King Ms Fau - Pryde, and K. R. Pryde. 2008. 'The production 
of reactive oxygen species by complex I', Biochem Soc Trans, 36: 976-80. 
83 
 
86. Hochachka Pw Fau - Storey, K. B., and K. B. Storey. 1975. 'Metabolic 
consequences of diving in animals and man', Science, 187: 613-21. 
87. Hossmann, K. A. 2009. 'Pathophysiological basis of translational stroke research', 
Folia Neuropathol, 47: 213-27. 
88. Hossmann Ka Fau - Sakaki, S., V. Sakaki S Fau - Zimmerman, and V. Zimmerman. 
1977. 'Cation activities in reversible ischemia of the cat brain', Stroke, 8: 77-81. 
89. Huh, P. W., W. Belayev L Fau - Zhao, S. Zhao W Fau - Koch, R. Koch S Fau - 
Busto, M. D. Busto R Fau - Ginsberg, and M. D. Ginsberg. 2009. 'Comparative 
neuroprotective efficacy of prolonged moderate intraischemic and postischemic 
hypothermia in focal cerebral ischemia', J Neurosurg, 92: 91-9. 
90. Huttemann, Maik, Icksoo Lee, Alena Pecinova, Petr Pecina, Karin Przyklenk, and 
Jeffrey W. Doan. 2008. 'Regulation of oxidative phosphorylation, the mitochondrial 
membrane potential, and their role in human disease', Journal of bioenergetics and 
biomembranes, 40: 445-56. 
91. Iijima, T., Kimio Mishima T Fau - Akagawa, Yasuhide Akagawa K Fau - Iwao, and 
Y. Iwao. 2006. 'Neuroprotective effect of propofol on necrosis and apoptosis 
following oxygen-glucose deprivation--relationship between mitochondrial 
membrane potential and mode of death', Brain Res, 1099: 25-32. 
92. Ishimaru, M. J., T. I. Ikonomidou C Fau - Tenkova, T. C. Tenkova Ti Fau - Der, K. 
Der Tc Fau - Dikranian, M. A. Dikranian K Fau - Sesma, J. W. Sesma Ma Fau - 
Olney, and J. W. Olney. 1999. 'Distinguishing excitotoxic from apoptotic 
neurodegeneration in the developing rat brain', J Comp Neurol, 408: 461-76. 
93. Jansen O Fau - Schellinger, P., J. Schellinger P Fau - Fiebach, W. Fiebach J Fau 
- Hacke, K. Hacke W Fau - Sartor, and K. Sartor. 1999. 'Early recanalisation in 
84 
 
acute ischaemic stroke saves tissue at risk defined by MRI', Lancet (London, 
England), 353: 2036-7. 
94. Kadenbach, B., Li Ramzan R Fau - Wen, Sebastian Wen L Fau - Vogt, and S. 
Vogt. 2010. 'New extension of the Mitchell Theory for oxidative phosphorylation in 
mitochondria of living organisms', Biochem Biophys Acta, 1800: 205-12. 
95. Karu, T. 1999. 'Primary and secondary mechanisms of action of visible to near-IR 
radiation on cells', Journal of photochemistry and photobiology. B, Biology, 49: 1-
17. 
96. Karu, T. I., and N. I. Afanas'eva. 1995. '[Cytochrome c oxidase as the primary 
photoacceptor upon laser exposure of cultured cells to visible and near IR-range 
light]', Doklady Akademii nauk, 342: 693-95. 
97. Kim, S. G. 1995. 'Quantification of relative cerebral blood flow change by flow-
sensitive alternating inversion recovery (FAIR) technique: application to functional 
mapping', Magn Reson Med, 34: 293-301. 
98. Kimelberg, H. K. 2004. 'Water homeostasis in the brain: basic concepts', 
Neuroscience, 129: 851-60. 
99. Kingsley, P. B., and W. G. Monahan. 2004. 'Selection of the optimum b factor for 
diffusion-weighted magnetic resonance imaging assessment of ischemic stroke', 
Magn Reson Med, 51: 996-1001. 
100. Knauth, M., O. von Kummer R Fau - Jansen, S. Jansen O Fau - Hahnel, A. Hahnel 
S Fau - Dorfler, K. Dorfler A Fau - Sartor, and K. Sartor. 1997. 'Potential of CT 
angiography in acute ischemic stroke', AJNR Am J Neuroradiol, 18: 1001-10. 
101. Koroshetz Wj Fau - Gonzalez, G., and G. Gonzalez. 1997. 'Diffusion-weighted 
MRI: an ECG for "brain attack"?', Ann Neurol, 41: 565-6. 
85 
 
102. Korshunov, S. S., A. A. Skulachev Vp Fau - Starkov, and A. A. Starkov. 1997. 'High 
protonic potential actuates a mechanism of production of reactive oxygen species 
in mitochondria', FEBS Letters, 416: 15-18. 
103. Krebs, H. A., A. Ruffo, Monica Johnson, L. V. Eggleston, and R. Hems. 1953. 
'Oxidative phosphorylation', Biochemical Journal, 54: 107-16. 
104. Kuboyama, K., A. Safar P Fau - Radovsky, S. A. Radovsky A Fau - Tisherman, S. 
W. Tisherman Sa Fau - Stezoski, H. Stezoski Sw Fau - Alexander, and H. 
Alexander. 1993. 'Delay in cooling negates the beneficial effect of mild 
resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, 
randomized study', Crit Care Med, 21: 1348-58. 
105. Kudin, A. P., Stefan Bimpong-Buta Ny Fau - Vielhaber, Christian E. Vielhaber S 
Fau - Elger, Wolfram S. Elger Ce Fau - Kunz, and W. S. Kunz. 2004. 
'Characterization of superoxide-producing sites in isolated brain mitochondria', J 
Biol Chem, 279: 4127-35. 
106. Kudin, A. P., Wolfram S. Malinska D Fau - Kunz, and W. S. Kunz. 2008. 'Sites of 
generation of reactive oxygen species in homogenates of brain tissue determined 
with the use of respiratory substrates and inhibitors', Biochem Biophys Acta, 1777: 
689-95. 
107. Kunimatsu, T., Anzu Kobayashi K Fau - Yamashita, Toshiharu Yamashita A Fau - 
Yamamoto, Masaichi-Chang-il Yamamoto T Fau - Lee, and M. C. Lee. 2011. 
'Cerebral reactive oxygen species assessed by electron spin resonance 
spectroscopy in the initial stage of ischemia-reperfusion are not associated with 
hypothermic neuroprotection', J Clin Neurosci, 18: 545-8. 
108. Kunz, W. S. et al. 2000. 'Flux control of cytochrome c oxidase in human skeletal 
86 
 
muscle', J Biol Chem, 275: 27741-45. 
109. Kussmaul, L., and J. Hirst. 2006. 'The mechanism of superoxide production by 
NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria', 
Proceedings of the National Academy of Sciences, 103: 7607-12. 
110. Kuwana, T., and D. D. Newmeyer. 2003. 'Bcl-2-family proteins and the role of 
mitochondria in apoptosis', Curr Opin Cell Biol, 15: 691-9. 
111. Lambert, A. J. and Brand, M. D. 2004. 'Superoxide production by 
NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across 
the mitochondrial inner membrane.', Biochem. J., 382: 511-17. 
112. Lapchak, P. A., Linda J. Zhang Jh Fau - Noble-Haeusslein, and L. J. Noble-
Haeusslein. 2013. 'RIGOR guidelines: escalating STAIR and STEPS for effective 
translational research', Transl Stroke Res, 4: 279-85. 
113. Lapchak, P.A. et al. . 2007. 'Transcranial near-infrared light therapy improves 
motor function following embolic strokes in rabbits: an extended therapeutic 
window study using continuous and pulse frequency delivery modes', 
Neuroscience, 148: 907-14. 
114. Lapchak, P.A., J Wei, and J.A. Zivin. 2004. 'Transcranial infrared laser therapy 
improves clinical rating scores after embolic strokes in rabbits', Stroke, 35: 198508. 
115. Lauterbur, P. C. 1973. 'Image Formation by Induced Local Interactions: Examples 
Employing Nuclear Magnetic Resonance', Nature, 242: 190. 
116. Lee, I., Scott Salomon Ar Fau - Ficarro, Isabella Ficarro S Fau - Mathes, Friedrich 
Mathes I Fau - Lottspeich, Lawrence I. Lottspeich F Fau - Grossman, Maik 
Grossman Li Fau - Huttemann, and M. Huttemann. 2005. 'cAMP-dependent 
tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity', J Biol 
87 
 
Chem, 280: 6094-100. 
117. Lee, I., Kebing Salomon Ar Fau - Yu, Jeffrey W. Yu K Fau - Doan, Lawrence I. 
Doan Jw Fau - Grossman, Maik Grossman Li Fau - Huttemann, and M. Huttemann. 
2006. 'New prospects for an old enzyme: mammalian cytochrome c is tyrosine-
phosphorylated in vivo', Biochemistry, 45: 9121-8. 
118. Lee, Jin-Moo, Gregory J. Zipfel, and Dennis W. Choi. 1999. 'The changing 
landscape of ischaemic brain injury mechanisms', Nature, 399: A7. 
119. Lees, K. R., Peter D. Bath Pm Fau - Schellinger, Daniel M. Schellinger Pd Fau - 
Kerr, Rachael Kerr Dm Fau - Fulton, Werner Fulton R Fau - Hacke, David Hacke 
W Fau - Matchar, Ruchir Matchar D Fau - Sehra, Danilo Sehra R Fau - Toni, and 
D. Toni. 2012. 'Contemporary outcome measures in acute stroke research: choice 
of primary outcome measure', Stroke, 43: 1163-70. 
120. Lees, Kennedy R., Justin A. Zivin, Tim Ashwood, Antonio Davalos, Stephen M. 
Davis, Hans-Christoph Diener, James Grotta, Patrick Lyden, Ashfaq Shuaib, 
Hans-Göran Hårdemark, and Warren W. Wasiewski. 2006. 'NXY-059 for Acute 
Ischemic Stroke', New England Journal of Medicine, 354: 588-600. 
121. Lenaz, Giorgio, Romana Fato, Maria Luisa Genova, Christian Bergamini, Cristina 
Bianchi, and Annalisa Biondi. 2006. 'Mitochondrial Complex I: Structural and 
functional aspects', Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1757: 
1406-20. 
122. Leonard, DR., M.H. Farooqui, and S Myers. 2004. 'Restoration of sensation, 
reduced pain, and improved balance in subjects with diabetic peripheral 
neuropathy: a double-blind, randomized, placebo-controlled study with 
monochromatic near infrared light treatement', Diabetes Care, 27: 168-72. 
88 
 
123. Leonov, Y., P. Sterz F Fau - Safar, A. Safar P Fau - Radovsky, K. Radovsky A Fau 
- Oku, S. Oku K Fau - Tisherman, S. W. Tisherman S Fau - Stezoski, and S. W. 
Stezoski. 1990. 'Mild cerebral hypothermia during and after cardiac arrest 
improves neurologic outcome in dogs', J Cereb Blood Flow Metab, 10: 57-70. 
124. Leonov, Y., P. Sterz F Fau - Safar, A. Safar P Fau - Radovsky, and A. Radovsky. 
1990. 'Moderate hypothermia after cardiac arrest of 17 minutes in dogs. Effect on 
cerebral and cardiac outcome', Stroke, 21: 1600-6. 
125. Liang, Danny, Sergei Bhatta, Volodymyr Gerzanich, and J. Marc Simard. 2007. 
'Cytotoxic edema: mechanisms of pathological cell swelling', Neurosurgical focus, 
22: E2-E2. 
126. Liebeskind, D. S. 2003. 'Collateral circulation', Stroke, 34: 2279-84. 
127. Lim, J et al. . 2009. 'Effects of low-level light herapy on hepatic antioxidant defense 
in acute and chronic diabetic rats', J Biochem Mol Toxicol, 23: 1-8. 
128. Lipton, P. 1999. 'Ischemic cell death in brain neurons', Physiol Rev, 79: 1431-568. 
129. Liu, S. S. 1997. 'Generating, partitioning, targeting and functioning of superoxide 
in mitochondria.', Biosc. Rep, 17: 259-72. 
130. Liu SS. 1999. 'Cooperation of a "reactive oxygen cycle" with the Q cycle and the 
proton cycle in the respiratory chain--superoxide generating and cycling 
mechanisms in mitochondria', J Bioenerg Biomembr, 31: 367-76. 
131. Liu SS. 2010. 'Mitochondrial Q cycle-derived superoxide and chemiosmotic 
bioenergetics', Ann NY Acad Sci, 1201: 84-95. 
132. Liu, T. T., and G. G. Brown. 2007. 'Measurement of cerebral perfusion with arterial 
spin labeling: Part 1. Methods', J Int Neuropsychol Soc, 13: 517-25. 
133. Liu, Y., David Fiskum G Fau - Schubert, and D. Schubert. 2002. 'Generation of 
89 
 
reactive oxygen species by the mitochondrial electron transport chain', J 
Neurochem, 80: 780-7. 
134. Lutsep, H. L., G. W. Albers, A. Decrespigny, G. N. Kamat, M. P. Marks, and M. E. 
Moseley. 2004. 'Clinical utility of diffusion-weighted magnetic resonance imaging 
in the assessment of ischemic stroke', Annals of neurology, 41: 574-80. 
135. MacIntosh, B. J., Michael A. Filippini N Fau - Chappell, Mark W. Chappell Ma Fau 
- Woolrich, Clare E. Woolrich Mw Fau - Mackay, Peter Mackay Ce Fau - Jezzard, 
and P. Jezzard. 2010. 'Assessment of arterial arrival times derived from multiple 
inversion time pulsed arterial spin labeling MRI', Magn Reson Med, 63: 641-7. 
136. MacManus, J. P., and M. D. Linnik. 1997. 'Gene expression induced by cerebral 
ischemia: an apoptotic perspective', J Cereb Blood Flow Metab, 17: 815-32. 
137. MacManus, John P., and Alastair M. Buchan. 2000. 'Apoptosis After Experimental 
Stroke: Fact or Fashion?', Journal of Neurotrauma, 17: 899-914. 
138. Maier, C. M., D. Sun Gh Fau - Kunis, M. A. Kunis D Fau - Yenari, G. K. Yenari Ma 
Fau - Steinberg, and G. K. Steinberg. 2001. 'Delayed induction and long-term 
effects of mild hypothermia in a focal model of transient cerebral ischemia: 
neurological outcome and infarct size', J Neurosurg, 94: 90-6. 
139. Majno, G., and I. Joris. 1995. 'Apoptosis, oncosis, and necrosis. An overview of 
cell death', Am J Pathol, 146: 3-15. 
140. Marks, M. P., D. de Crespigny A Fau - Lentz, D. R. Lentz D Fau - Enzmann, G. W. 
Enzmann Dr Fau - Albers, M. E. Albers Gw Fau - Moseley, and M. E. Moseley. 
1996. 'Acute and chronic stroke: navigated spin-echo diffusion-weighted MR 
imaging', Radiology, 199: 403-8. 
141. Martin, L. J., A. M. Al-Abdulla Na Fau - Brambrink, J. R. Brambrink Am Fau - 
90 
 
Kirsch, F. E. Kirsch Jr Fau - Sieber, C. Sieber Fe Fau - Portera-Cailliau, and C. 
Portera-Cailliau. 1998. 'Neurodegeneration in excitotoxicity, global cerebral 
ischemia, and target deprivation: A perspective on the contributions of apoptosis 
and necrosis', Brain Res Bull, 46: 281-309. 
142. Mason, MG., Nicholls, P., Cooper, CE. 2014. 'Re-evaluation of the near infrared 
spectra of mitochondrial cytochrome c oxidase: Implications for non-invasive in 
vivo monitoring of tissues', Biochem Biophys Acta, 1837: 1882-91. 
143. Mergenthaler, P., and A. Meisel. 2012. 'Do stroke models model stroke?', Dis 
Model Merch, 5: 718-25. 
144. Merten, C. L., J. Knitelius Ho Fau - Assheuer, B. Assheuer J Fau - Bergmann-
Kurz, J. P. Bergmann-Kurz B Fau - Hedde, H. Hedde Jp Fau - Bewermeyer, and 
H. Bewermeyer. 1999. 'MRI of acute cerebral infarcts, increased contrast 
enhancement with continuous infusion of gadolinium', Neuroradiology, 41: 242-8. 
145. Michalet, Xavier. 2010. 'Mean Square Displacement Analysis of Single-Particle 
Trajectories with Localization Error: Brownian Motion in Isotropic Medium', 
Physical review. E, Statistical, nonlinear, and soft matter physics, 82: 041914-14. 
146. Mies, G., S. Ishimaru, Y. Xie, K. Seo, and K. A. Hossmann. 1991. 'Ischemic 
thresholds of cerebral protein synthesis and energy state following middle cerebral 
artery occlusion in rat', Journal of cerebral blood flow and metabolism : official 
journal of the International Society of Cerebral Blood Flow and Metabolism, 11: 
753-61. 
147. Hypothermia after Cardiac Arrest Study Group. 'Mild therapeutic hypothermia to 
improve the neurologic outcome after cardiac arrest'. 2002. New England Journal 
of Medicine: 549-56. 
91 
 
148. Mitchell Dg Fau - Burk, D. L., Jr., S. Burk Dl Jr Fau - Vinitski, M. D. Vinitski S Fau 
- Rifkin, and M. D. Rifkin. 1987. 'The biophysical basis of tissue contrast in 
extracranial MR imaging', AJR Am J Roentgenol, 149: 831-7. 
149. Mitchell, P. 1975a. 'The protonmotive Q cycle: a general formulation', FEBS 
Letters, 59: 137-39. 
150. Mitchell P. 1975b. 'Protonmotive redox mechanism b-c1 complex in the respiratory 
chain: protonmotive ubiquinone cycle', FEBS Letters, 56: 1-6. 
151. Mitchell, Peter, and Jennifer Moyle. 1967. 'Chemiosmotic Hypothesis of Oxidative 
Phosphorylation', Nature, 213: 137. 
152. Modo, M., R. P. Stroemer, E. Tang, T. Veizovic, P. Sowniski, and H. Hodges. 2000. 
'Neurological sequelae and long-term behavioural assessment of rats with 
transient middle cerebral artery occlusion', Journal of Neuroscience Methods, 104: 
99-109. 
153. Mohr, J. P., S. K. Biller J Fau - Hilal, W. T. Hilal Sk Fau - Yuh, T. K. Yuh Wt Fau - 
Tatemichi, S. Tatemichi Tk Fau - Hedges, E. Hedges S Fau - Tali, H. Tali E Fau - 
Nguyen, I. Nguyen H Fau - Mun, H. P. Mun I Fau - Adams, Jr., H. P. Adams, Jr., 
and et al. 1995. 'Magnetic resonance versus computed tomographic imaging in 
acute stroke', Stroke, 26: 807-12. 
154. Moseley, M. E., J. Cohen Y Fau - Mintorovitch, L. Mintorovitch J Fau - Chileuitt, H. 
Chileuitt L Fau - Shimizu, J. Shimizu H Fau - Kucharczyk, M. F. Kucharczyk J Fau 
- Wendland, P. R. Wendland Mf Fau - Weinstein, and P. R. Weinstein. 1990. 'Early 
detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-
weighted MRI and spectroscopy', Magn Reson Med, 14: 330-46. 
155. Moseley, M. E., J. Kucharczyk J Fau - Mintorovitch, Y. Mintorovitch J Fau - Cohen, 
92 
 
J. Cohen Y Fau - Kurhanewicz, N. Kurhanewicz J Fau - Derugin, H. Derugin N Fau 
- Asgari, D. Asgari H Fau - Norman, and D. Norman. 1990. 'Diffusion-weighted MR 
imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-
enhanced MR imaging in cats', AJNR Am J Neuroradiol, 11: 423-9. 
156. Murphy, M. P. 2009. 'How mitochondria produce reactive oxygen species', 
Biochem J, 417: 1-13. 
157. Niatsetskaya, Z. V., Dzmitry Sosunov Sa Fau - Matsiukevich, Irina V. Matsiukevich 
D Fau - Utkina-Sosunova, Veniamin I. Utkina-Sosunova Iv Fau - Ratner, Anatoly 
A. Ratner Vi Fau - Starkov, Vadim S. Starkov Aa Fau - Ten, and V. S. Ten. 2012. 
'The oxygen free radicals originating from mitochondrial complex I contribute to 
oxidative brain injury following hypoxia-ischemia in neonatal mice', J Neurosci, 32: 
3235-44. 
158. Northington, F. J., E. M. Ferriero Dm Fau - Graham, R. J. Graham Em Fau - 
Traystman, L. J. Traystman Rj Fau - Martin, and L. J. Martin. 2001. 'Early 
Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while 
Delayed Neuronal Death Is Apoptosis', Neurobiol Dis, 8: 207-19. 
159. Ogbi, M., Jan Chew Cs Fau - Pohl, Olga Pohl J Fau - Stuchlik, Safia Stuchlik O 
Fau - Ogbi, John A. Ogbi S Fau - Johnson, and J. A. Johnson. 2004. 'Cytochrome 
c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal 
cardiac myocytes: implications for cytochrome c oxidase activity', Biochem J, 382: 
923-32. 
160. Ogbi, M., and J. A. Johnson. 2006. 'Protein kinase Cepsilon interacts with 
cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in 
neonatal cardiac myocyte preconditioning', Biochem J, 393: 191-9. 
93 
 
161. Oron, A., et al., . 2006. 'Low-level laser therapy applied transcranially to rats after 
induction of stroke significantly reduces long-term neurological deficits', Stroke, 37: 
2620-4. 
162. Osyczka, A., Moser, C.C. & Dutton, P.L. 2005. 'Fixing the Q cycle', Trends in 
Biochemical Sciences, 30: 176-82. 
163. Ouyang, Y. B., M. Tan Y Fau - Comb, C. L. Comb M Fau - Liu, M. E. Liu Cl Fau - 
Martone, B. K. Martone Me Fau - Siesjo, B. R. Siesjo Bk Fau - Hu, and B. R. Hu. 
1999. 'Survival- and death-promoting events after transient cerebral ischemia: 
phosphorylation of Akt, release of cytochrome C and Activation of caspase-like 
proteases', J Cereb Blood Flow Metab, 19: 1126-35. 
164. Pandya JD1, Pauly JR, Sullivan PG. 2009. 'The optimal dosage and window of 
opportunity to maintain mitochondrial homeostasis following traumatic brain injury 
using the uncoupler FCCP', Exp Neurol, 218: 381-9. 
165. Parsons, M. W., Jonathon Barber Pa Fau - Chalk, David G. Chalk J Fau - Darby, 
Stephen Darby Dg Fau - Rose, Patricia M. Rose S Fau - Desmond, Richard P. 
Desmond Pm Fau - Gerraty, Brian M. Gerraty Rp Fau - Tress, Peter M. Tress Bm 
Fau - Wright, Geoffrey A. Wright Pm Fau - Donnan, Stephen M. Donnan Ga Fau - 
Davis, and S. M. Davis. 2002. 'Diffusion- and perfusion-weighted MRI response to 
thrombolysis in stroke', Ann Neurol, 51: 28-37. 
166. Parsons, M. W., Patrick Christensen S Fau - McElduff, Christopher R. McElduff P 
Fau - Levi, Ken S. Levi Cr Fau - Butcher, Deidre A. Butcher Ks Fau - De Silva, 
Martin De Silva Da Fau - Ebinger, P. Alan Ebinger M Fau - Barber, Christopher 
Barber Pa Fau - Bladin, Geoffrey A. Bladin C Fau - Donnan, Stephen M. Donnan 
Ga Fau - Davis, and S. M. Davis. 2010. 'Pretreatment diffusion- and perfusion-MR 
94 
 
lesion volumes have a crucial influence on clinical response to stroke 
thrombolysis', J Cereb Blood Flow Metab, 30: 1214-25. 
167. Pastore, D., M. Greco, and S. Passarella. 2000. 'Specific helium-neon laser 
sensitivity of the purified cytochrome c oxidase', International journal of radiation 
biology, 76: 863-70. 
168. Perez-Trepichio, Alejandro D., Min Xue, Thian C. Ng, Anthony W. Majors, Anthony 
J. Furlan, Issam A. Awad, and Stephen C. Jones. 1995. 'Sensitivity of Magnetic 
Resonance Diffusion-Weighted Imaging and Regional Relationship Between the 
Apparent Diffusion Coefficient and Cerebral Blood Flow in Rat Focal Cerebral 
Ischemia', Stroke, 26: 667. 
169. Petersen, E. T., Y. C. L. Zimine I Fau - Ho, X. Ho Yc Fau - Golay, and X. Golay. 
2006. 'Non-invasive measurement of perfusion: a critical review of arterial spin 
labelling techniques', Br J Radiol, 79: 688-701. 
170. Piantadosi, C. A., and J. Zhang. 1996. 'Mitochondrial generation of reactive oxygen 
species after brain ischemia in the rat', Stroke, 27: 327-31. 
171. Piccoli, C., Scrima, R., Boffoli, D. & Capitanio, N. 2006. 'Control by cytochrome c 
oxidase of the cellular oxidative phosphorylation system depends on the 
mitochondrial energy state.', Biochem J, 396: 573-83. 
172. Polderman, K. H. 2009. 'Mechanisms of action, physiological effects, and 
complications of hypothermia', Crit Care Med, 37: S186-202. 
173. Powers, William J., Alejandro A. Rabinstein, Teri Ackerson, Opeolu M. Adeoye, 
Nicholas C. Bambakidis, Kyra Becker, José Biller, Michael Brown, Bart M. 
Demaerschalk, Brian Hoh, Edward C. Jauch, Chelsea S. Kidwell, Thabele M. 
Leslie-Mazwi, Bruce Ovbiagele, Phillip A. Scott, Kevin N. Sheth, Andrew M. 
95 
 
Southerland, Deborah V. Summers, and David L. Tirschwell. 2018. '2018 
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A 
Guideline for Healthcare Professionals From the American Heart 
Association/American Stroke Association', Stroke. 
174. Prabu, S. K., Haider Anandatheerthavarada Hk Fau - Raza, Satish Raza H Fau - 
Srinivasan, Joseph F. Srinivasan S Fau - Spear, Narayan G. Spear Jf Fau - 
Avadhani, and N. G. Avadhani. 2006. 'Protein kinase A-mediated phosphorylation 
modulates cytochrome c oxidase function and augments hypoxia and myocardial 
ischemia-related injury', J Biol Chem, 281: 2061-70. 
175. Proskuryakov, S. Y., Vladimir L. Konoplyannikov Ag Fau - Gabai, and V. L. Gabai. 
2003. 'Necrosis: a specific form of programmed cell death?', Exp Cell Res, 283: 1-
16. 
176. Pryde, K. R., and J. Hirst. 2011. 'Superoxide is produced by the reduced flavin in 
mitochondrial complex I: a single, unified mechanism that applies during both 
forward and reverse electron transfer', J Biol Chem, 286: 18056-65. 
177. Puka-Sundvall, M., M. Gajkowska B Fau - Cholewinski, K. Cholewinski M Fau - 
Blomgren, J. W. Blomgren K Fau - Lazarewicz, H. Lazarewicz Jw Fau - Hagberg, 
and H. Hagberg. 2000. 'Subcellular distribution of calcium and ultrastructural 
changes after cerebral hypoxia-ischemia in immature rats', Brain Res Dev Brain 
Res, 125: 31-41. 
178. Rabi, I. I., J. R. Zacharias, S. Millman, and P. Kusch. 1938. 'A New Method of 
Measuring Nuclear Magnetic Moment', Physical Review, 53: 318-18. 
179. Raedschelders, K., David D. Y. Ansley Dm Fau - Chen, and D. D. Chen. 2012. 
'The cellular and molecular origin of reactive oxygen species generation during 
96 
 
myocardial ischemia and reperfusion', Pharmacol Ther, 133: 230-55. 
180. Reith, W., Y. Hasegawa, L. L. Latour, B. J. Dardzinski, C. H. Sotak, and M. Fisher. 
1995. 'Multislice diffusion mapping for 3-D evolution of cerebral ischemia in a rat 
stroke model', Neurology, 45: 172. 
181. Rewell, S. S. Auid-Orcid http orcid org, L. Churilov, T. K. Sidon, E. Aleksoska, S. 
F. Cox, M. R. Macleod, and D. W. Howells. 2017. 'Evolution of ischemic damage 
and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal 
outcomes and statistical power for multi-centre preclinical trials', PLoS One, 12. 
182. Reynolds, Christian A. 2015. 'Preclinical evaluation of infrared light therapy in a rat 
model of neonatal hypoxic-ischemic encephalopathy', Dissertation Wayne State 
University  
183. Rosen, B. R., J. M. Belliveau Jw Fau - Vevea, T. J. Vevea Jm Fau - Brady, and T. 
J. Brady. 1990. 'Perfusion imaging with NMR contrast agents', Magn Reson Med, 
14: 249-65. 
184. Rungta, R. L., H. B. Choi, J. R. Tyson, A. Malik, L. Dissing-Olesen, P. J. C. Lin, S. 
M. Cain, P. R. Cullis, T. P. Snutch, and B. A. MacVicar. 2015. 'The cellular 
mechanisms of neuronal swelling underlying cytotoxic edema', Cell, 161: 610-21. 
185. Safar, P., A. Xiao F Fau - Radovsky, K. Radovsky A Fau - Tanigawa, U. Tanigawa 
K Fau - Ebmeyer, N. Ebmeyer U Fau - Bircher, H. Bircher N Fau - Alexander, S. 
W. Alexander H Fau - Stezoski, and S. W. Stezoski. 1996. 'Improved cerebral 
resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow 
promotion', Stroke, 27: 105-13. 
186. Sanderson, T. H., Jonathon M. Kumar R Fau - Sullivan, Gary S. Sullivan Jm Fau - 
Krause, and G. S. Krause. 2008. 'Insulin blocks cytochrome c release in the 
97 
 
reperfused brain through PI3-K signaling and by promoting Bax/Bcl-XL binding', J 
Neurochem, 106: 1248-58. 
187. Sanderson, Thomas H., Christian A. Reynolds, Rita Kumar, Karin Przyklenk, and 
Maik Huttemann. 2013. 'Molecular mechanisms of ischemia-reperfusion injury in 
brain: pivotal role of the mitochondrial membrane potential in reactive oxygen 
species generation', Molecular neurobiology, 47: 9-23. 
188. Sanderson, Thomas H., Joseph M. Wider, Icksoo Lee, Christian A. Reynolds, 
Jenney Liu, Bradley Lepore, Reneé Tousignant, Melissa J. Bukowski, Hollie 
Johnston, Alemu Fite, Sarita Raghunayakula, John Kamholz, Lawrence I. 
Grossman, Karin Przyklenk, and Maik Hüttemann. 2018. 'Inhibitory modulation of 
cytochrome c oxidase activity with specific near-infrared light wavelengths 
attenuates brain ischemia/reperfusion injury', Scientific Reports, 8: 3481-81. 
189. Sazanov, L. A. 2007. 'Respiratory complex I: mechanistic and structural insights 
provided by the crystal structure of the hydrophilic domain', Biochemistry, 46: 
2275-88. 
190. Schellinger, P. D., Kennedy R. Bath Pm Fau - Lees, Natan M. Lees Kr Fau - 
Bornstein, Eitan Bornstein Nm Fau - Uriel, Wolfgang Uriel E Fau - Eisert, Didier 
Eisert W Fau - Leys, and D. Leys. 2012. 'Assessment of additional endpoints for 
trials in acute stroke - what, when, where, in who?', Int J Stroke, 7: 227-30. 
191. Schellinger, P. D., O. Fiebach Jb Fau - Jansen, P. A. Jansen O Fau - Ringleb, A. 
Ringleb Pa Fau - Mohr, T. Mohr A Fau - Steiner, S. Steiner T Fau - Heiland, S. 
Heiland S Fau - Schwab, O. Schwab S Fau - Pohlers, H. Pohlers O Fau - Ryssel, 
B. Ryssel H Fau - Orakcioglu, K. Orakcioglu B Fau - Sartor, W. Sartor K Fau - 
Hacke, and W. Hacke. 2001. 'Stroke magnetic resonance imaging within 6 hours 
98 
 
after onset of hyperacute cerebral ischemia', Ann Neurol, 49: 460-9. 
192. Schlaug, G., A. Siewert B Fau - Benfield, R. R. Benfield A Fau - Edelman, S. 
Edelman Rr Fau - Warach, and S. Warach. 1997. 'Time course of the apparent 
diffusion coefficient (ADC) abnormality in human stroke', Neurology, 49: 113-9. 
193. Schulz, J. B., M. A. Weller M Fau - Moskowitz, and M. A. Moskowitz. 1999. 
'Caspases as treatment targets in stroke and neurodegenerative diseases', Ann 
Neurol, 45: 421-9. 
194. Sevick, R. J., J. Kanda F Fau - Mintorovitch, A. I. Mintorovitch J Fau - Arieff, J. 
Arieff Ai Fau - Kucharczyk, J. S. Kucharczyk J Fau - Tsuruda, D. Tsuruda Js Fau 
- Norman, M. E. Norman D Fau - Moseley, and M. E. Moseley. 1992. 'Cytotoxic 
brain edema: assessment with diffusion-weighted MR imaging', Radiology, 185: 
687-90. 
195. Shrier, D. A., Y. Tanaka H Fau - Numaguchi, S. Numaguchi Y Fau - Konno, U. 
Konno S Fau - Patel, D. Patel U Fau - Shibata, and D. Shibata. 1997. 'CT 
angiography in the evaluation of acute stroke', AJNR Am J Neuroradiol, 18: 1011-
20. 
196. Shuaib, Ashfaq, Kennedy R. Lees, Patrick Lyden, James Grotta, Antonio Davalos, 
Stephen M. Davis, Hans-Christoph Diener, Tim Ashwood, Warren W. Wasiewski, 
and Ugochi Emeribe. 2007. 'NXY-059 for the Treatment of Acute Ischemic Stroke', 
New England Journal of Medicine, 357: 562-71. 
197. Singer, Michael B., June Chong, Dongfeng Lu, Wouter J. Schonewille, Stanley 
Tuhrim, and Scott W. Atlas. 1998. 'Diffusion-Weighted MRI in Acute Subcortical 
Infarction', Stroke, 29: 133. 
198. Song, Y., and G. R. Buettner. 2010. 'Thermodynamic and kinetic considerations 
99 
 
for the reaction of semiquinone radicals to form superoxide and hydrogen 
peroxide', Free Radic Biol Med, 49: 919-62. 
199. Sorensen, A. G., R. G. Buonanno Fs Fau - Gonzalez, L. H. Gonzalez Rg Fau - 
Schwamm, M. H. Schwamm Lh Fau - Lev, F. R. Lev Mh Fau - Huang-Hellinger, T. 
G. Huang-Hellinger Fr Fau - Reese, R. M. Reese Tg Fau - Weisskoff, T. L. 
Weisskoff Rm Fau - Davis, N. Davis Tl Fau - Suwanwela, U. Suwanwela N Fau - 
Can, J. A. Can U Fau - Moreira, W. A. Moreira Ja Fau - Copen, R. B. Copen Wa 
Fau - Look, S. P. Look Rb Fau - Finklestein, B. R. Finklestein Sp Fau - Rosen, W. 
J. Rosen Br Fau - Koroshetz, and W. J. Koroshetz. 1996. 'Hyperacute stroke: 
evaluation with combined multisection diffusion-weighted and hemodynamically 
weighted echo-planar MR imaging', Radiology, 199: 391-01. 
200. Sridharan, V., Chuan-Yuan Guichard J Fau - Li, Robin Li Cy Fau - Muise-
Helmericks, Craig Cano Muise-Helmericks R Fau - Beeson, Gary L. Beeson Cc 
Fau - Wright, and G. L. Wright. 2008. 'O(2)-sensing signal cascade: clamping of 
O(2) respiration, reduced ATP utilization, and inducible fumarate respiration', Am 
J Physiol Cell Physiol, 295: C29-C37. 
201. St-Pierre, J., Stephen J. Buckingham Ja Fau - Roebuck, Martin D. Roebuck Sj Fau 
- Brand, and M. D. Brand. 2002. 'Topology of superoxide production from different 
sites in the mitochondrial electron transport chain', J Biol Chem, 277: 44784-90. 
202. Starkov, A. A., and G. Fiskum. 2002. 'Regulation of brain mitochondrial H2O2 
production by membrane potential and NAD(P)H redox state', J Neurochem, 86: 
1101-7. 
203. Steenaart NA, and GC Shore. 1997. 'Mitochondrial cytochrome c oxidase subunit 
IV is phosphorylated by an endogenous kinase', FEBS Letters, 415: 294-98. 
100 
 
204. Stejskal, E. O., and J. E. Tanner. 1965. 'Spin Diffusion Measurements: Spin 
Echoes in the Presence of a Time‐Dependent Field Gradient', The Journal of 
Chemical Physics, 42: 288-92. 
205. Sterz, F., S. Safar P Fau - Tisherman, A. Tisherman S Fau - Radovsky, K. 
Radovsky A Fau - Kuboyama, K. Kuboyama K Fau - Oku, and K. Oku. 1991. 'Mild 
hypothermic cardiopulmonary resuscitation improves outcome after prolonged 
cardiac arrest in dogs', Crit Care Med, 19: 379-89. 
206. Streeter, J., De Taboada, U. Oron. 2004. 'Mechanism of action of light therapy for 
stroke and acute myocardial infarction', Mitochondrion, 4: 569-76. 
207. Sugawara, T., Y. Fujimura M Fau - Morita-Fujimura, M. Morita-Fujimura Y Fau - 
Kawase, P. H. Kawase M Fau - Chan, and P. H. Chan. 1999. 'Mitochondrial 
release of cytochrome c corresponds to the selective vulnerability of hippocampal 
CA1 neurons in rats after transient global cerebral ischemia', J Neurosci, 19. 
208. Suski, J. M., Massimo Lebiedzinska M Fau - Bonora, Paolo Bonora M Fau - Pinton, 
Jerzy Pinton P Fau - Duszynski, Mariusz R. Duszynski J Fau - Wieckowski, and 
M. R. Wieckowski. 2012. 'Relation between mitochondrial membrane potential and 
ROS formation', Methods Mol Biol, 810: 183-205. 
209. Szabo, C. 2008. 'Mechanisms of cell necrosis', Curr Mol Med, 8: 207-20. 
210. Taegtmeyer, H. 1978. 'Metabolic responses to cardiac hypoxia. Increased 
production of succinate by rabbit papillary muscles', Circ Res, 43: 808-15. 
211. Taylor, D. L., Ernest B. Mehmet H Fau - Cady, A. David Cady Eb Fau - Edwards, 
and A. D. Edwards. 2002. 'Improved neuroprotection with hypothermia delayed by 
6 hours following cerebral hypoxia-ischemia in the 14-day-old rat', Pediatr Res, 51: 
13-9. 
101 
 
212. Tissier, R., Sandrine Chenoune M Fau - Pons, Roland Pons S Fau - Zini, Lys Zini 
R Fau - Darbera, Fanny Darbera L Fau - Lidouren, Bijan Lidouren F Fau - Ghaleh, 
Alain Ghaleh B Fau - Berdeaux, Didier Berdeaux A Fau - Morin, and D. Morin. 
2013. 'Mild hypothermia reduces per-ischemic reactive oxygen species production 
and preserves mitochondrial respiratory complexes', Resuscitation, 84: 249-55. 
213. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study 
Group 1995 'Tissue Plasminogen Activator for Acute Ischemic Stroke'. New 
England Journal of Medicine, 333: 1581-88. 
214. Tong, D. C., M. A. Yenari, G. W. Albers, M. Brien, M. P. Marks, and M. E. Moseley. 
1998. 'Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in 
acute (&amp;lt;6.5 hour) ischemic stroke', Neurology, 50: 864. 
215. Trumpower, B.I. 1976. 'Evidence for a protonmotive Q cycle mechanism of electron 
transfer through the cytochrome bc1 comples', Biochemical and Biophysical 
Research Communications, 70: 73-80. 
216. Tsukihara, T., E. Aoyama H Fau - Yamashita, T. Yamashita E Fau - Tomizaki, H. 
Tomizaki T Fau - Yamaguchi, K. Yamaguchi H Fau - Shinzawa-Itoh, R. Shinzawa-
Itoh K Fau - Nakashima, R. Nakashima R Fau - Yaono, S. Yaono R Fau - 
Yoshikawa, and S. Yoshikawa. 1996. 'The whole structure of the 13-subunit 
oxidized cytochrome c oxidase at 2.8 A', Science, 272: 1136-44. 
217. Turrens, Julio F., Adolfo Alexandre, and Albert L. Lehninger. 1985. 
'Ubisemiquinone is the electron donor for superoxide formation by complex III of 
heart mitochondria', Archives of Biochemistry and Biophysics, 237: 408-14. 
218. Van Bruggen, N., M. D. Cullen Bm Fau - King, M. King Md Fau - Doran, S. R. 
Doran M Fau - Williams, D. G. Williams Sr Fau - Gadian, J. E. Gadian Dg Fau - 
102 
 
Cremer, and J. E. Cremer. 1992. 'T2- and diffusion-weighted magnetic resonance 
imaging of a focal ischemic lesion in rat brain', Stroke, 23: 576-82. 
219. Van den Berghe, G., J. Vincent Mf Fau - Jaeken, and J. Jaeken. 1997. 'Inborn 
errors of the purine nucleotide cycle: adenylosuccinase deficiency', J Inherit Metab 
Dis, 20: 193-202. 
220. Van Everdingen, K. J., J. van der Grond, L. J. Kappelle, L. M. P. Ramos, and W. 
P. T. M. Mali. 1998. 'Diffusion-Weighted Magnetic Resonance Imaging in Acute 
Stroke', Stroke, 29: 1783. 
221. Van Lookeren Campagne, M., and R. Gill. 1996. 'Ultrastructural morphological 
changes are not characteristic of apoptotic cell death following focal cerebral 
ischaemia in the rat', Neurosci Let, 213: 111-4. 
222. Villani, G. & Attardi, G. 1997. 'In vivo control of respiration by cytochrome c oxidase 
in wild-type and mitochondrial DNA mutation-carrying human cells.', Proceedings 
of the National Academy of Sciences of the United States of America, 94: 1166-
71. 
223. Votyakova, T. V. and Reynolds, I. J. 2001. 'Δψm-Dependent and -independent 
224. production of reactive oxygen species by rat brain mitochondria', J. Neurochem, 
79: 266-77. 
225. Wang, J., Lin Alsop Dc Fau - Li, John Li L Fau - Listerud, Julio B. Listerud J Fau - 
Gonzalez-At, Mitchell D. Gonzalez-At Jb Fau - Schnall, John A. Schnall Md Fau - 
Detre, and J. A. Detre. 2002. 'Comparison of quantitative perfusion imaging using 
arterial spin labeling at 1.5 and 4.0 Tesla', Magn Reson Med, 48: 242-54. 
226. Warach, S., R. R. Dashe Jf Fau - Edelman, and R. R. Edelman. 1996. 'Clinical 
outcome in ischemic stroke predicted by early diffusion-weighted and perfusion 
103 
 
magnetic resonance imaging: a preliminary analysis', J Cereb Blood Flow Metab, 
16: 53-9. 
227. Weerasinghe, P., and L. M. Buja. 2012. 'Oncosis: an important non-apoptotic 
mode of cell death', Exp Mol Pathol, 93: 302-8. 
228. Weinrauch, V., S. Safar P Fau - Tisherman, K. Tisherman S Fau - Kuboyama, A. 
Kuboyama K Fau - Radovsky, and A. Radovsky. 1992. 'Beneficial effect of mild 
hypothermia and detrimental effect of deep hypothermia after cardiac arrest in 
dogs', Stroke, 23: 1454-62. 
229. Wharton DC, Tzagoloff A. 1964. 'Studies on the Electron Transfer System. Lvii. 
The near Infrared Absorption Band of Cytochrome Oxidase', J Biol Chem, 239. 
230. Whelan, Harry T. 2003. 'Effect of NASA light-emitting diode irradiation on 
molecular changes for wound healing in diabetic mice', J Clin Laser Med Surg, 21: 
67-74. 
231. White, Blaine C., Lawrence I. Grossman, Brian J. O'Neil, Donald J. DeGracia, 
Robert W. Neumar, José A. Rafols, and Gary S. Krause. 1996. 'Global Brain 
Ischemia and Reperfusion', Annals of Emergency Medicine, 27: 588-94. 
232. Williams, D. S., J. A. Detre, J. S. Leigh, and A. P. Koretsky. 1992. 'Magnetic 
resonance imaging of perfusion using spin inversion of arterial water', Proceedings 
of the National Academy of Sciences of the United States of America, 89: 212-16. 
233. Williams, George S. B., Liron Boyman, Aristide C. Chikando, Ramzi J. Khairallah, 
and W. J. Lederer. 2013. 'Mitochondrial calcium uptake', Proceedings of the 
National Academy of Sciences of the United States of America, 110: 10479-86. 
234. Wolf, R. L., and J. A. Detre. 2007. 'Clinical neuroimaging using arterial spin-labeled 
perfusion magnetic resonance imaging', Neurotherapeutics, 4: 356-59. 
104 
 
235. Wong, E. C., Wen-Chau Cronin M Fau - Wu, Ben Wu Wc Fau - Inglis, Lawrence 
R. Inglis B Fau - Frank, Thomas T. Frank Lr Fau - Liu, and T. T. Liu. 2006. 'Velocity-
selective arterial spin labeling', Magn Reson Med, 55: 1334-41. 
236. Wong-Riley, Margaret T. T. 2001. 'Light-emitting diode treatment reverses the 
effect of TTX on cytochrome oxidase in neurons', Neuroreport, 12: 3033-7. 
237. Wong-Riley, Margaret T. T., Huan Ling Liang, Janis T. Eells, Britton Chance, 
Michele M. Henry, Ellen Buchmann, Mary Kane, and Harry T. Whelan. 2005. 
'Photobiomodulation directly benefits primary neurons functionally inactivated by 
toxins: role of cytochrome c oxidase', The Journal of biological chemistry, 280: 
4761-71. 
238. Wu, W. C., John A. Fernandez-Seara M Fau - Detre, Felix W. Detre Ja Fau - 
Wehrli, Jiongjiong Wehrli Fw Fau - Wang, and J. Wang. 2007. 'A theoretical and 
experimental investigation of the tagging efficiency of pseudocontinuous arterial 
spin labeling', Magn Reson Med, 58: 1020-7. 
239. Yeager, R.L., et al., . 2005. 'Effects of 670-nm photothereapy on development', 
Photomed Laser Surg, 23: 268-72. 
240. Yellen, G. Auid-Orcid http orcid org. 2018. 'Fueling thought: Management of 
glycolysis and oxidative phosphorylation in neuronal metabolism', J Cell Biol, 217: 
2235-46. 
241. Yu, H., Arthur R. Lee I Fau - Salomon, Kebing Salomon Ar Fau - Yu, Maik Yu K 
Fau - Huttemann, and M. Huttemann. 2008. 'Mammalian liver cytochrome c is 
tyrosine-48 phosphorylated in vivo, inhibiting mitochondrial respiration', Biochem 
Biophys Acta, 17777: 1066-71. 
242. Yu, W., et al. 1997. 'Photomodulation of oxidative metabolism and electron chain 
105 
 
enzymes in rat liver mitochondria', Photochem Photobiol, 66: 866-71. 
243. Zhang, W., D. S. Silva Ac Fau - Williams, A. P. Williams Ds Fau - Koretsky, and A. 
P. Koretsky. 1995. 'NMR measurement of perfusion using arterial spin labeling 
without saturation of macromolecular spins', Magn Reson Med, 33: 370-6. 
244. Zimmerman, J. J. 1995. 'Defining the role of oxyradicals in the pathogenesis of 
sepsis', Crit Care Med, 23: 616-7. 
 
 
  
106 
 
ABSTRACT 
NON-INVASIVE MITOCHONDRIAL MODULATION WITH NEAR-INFRARED LIGHT 
REDUCES BRAIN INJURY AFTER STROKE 
by 
CHRISTOS DIONISOS STRUBAKOS 
December 2018 
Advisors: Maik Huttemann, Ph.D. and Thomas Sanderson, Ph.D. 
Major: Physiology  
Degree: Doctor of Philosophy 
Acute ischemic stroke is a debilitating disease that causes significant brain injury. 
While rapid restoration of blood flow is critical to salvage the ischemic brain, reperfusion 
of tissue can further drive brain damage by inducing generation of mitochondrial reactive 
oxygen species (Chouchani et al., 2014a). Recent studies by our group found that non-
invasive mitochondrial modulation (NIMM) with near-infrared (NIR) light can limit the 
production of reactive oxygen species following global brain ischemia (T. H. Sanderson 
et al., 2018).  NIR interacts with the rate limiting step of the mitochondrial electron 
transport chain (ETC), cytochrome c oxidase (COX), and modulates mitochondrial 
respiration. Under conditions of mitochondrial stress, such as reperfusion following 
ischemia, specific wavelengths of NIR can limit the production of ROS by transiently 
reducing COX activity, and thus limiting a critical force for ROS production, stress-induced 
mitochondrial membrane potential hyperpolarization. Here, we evaluated a specific 
combination of COX-inhibitory NIR (750nm and 950nm) as a potential therapy for acute 
ischemic stroke using a rat MCAO model. We found the NIMM at the onset of reperfusion 
resulted in a 20% reduction of infarct volume measured 24 hours post reperfusion.  This 
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reduction in infarct was sustained through the chronic phase of stroke and the 
neuroprotective benefit increased to 50% infarct reduction when treatment duration was 
douple to 240 minutes. Our data suggest that NIMM by targeting COX with NIR irradiation 
at the onset of reperfusion can be a beneficial therapy to minimize reperfusion injury 
following acute ischemic stroke and that extending the treatment window beyond the 
initial ROS burst can target other long-term causes of neuronal death following stroke 
such as inflammation. 
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